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The objective of our study was to investigate the effect of selenium on 
selenoprotein W. Western blot analysis indicated that selenoprotein W is present in 
muscle, brain, testis and spleen of rat tissues. Tissue distribution of selenoprotein W 
was not altered in rats fed various selenium levels. Among muscle, brain, testis and 
spleen, selenoprotein W in muscle was most responsive to selenium status, but brain 
appeared to be the least responsive organ. Northern blot data indicated that 
selenoprotein W mRNA in rat muscle increased significantly as levels of selenium 
supplementation increased. Western blot data indicate that selenoprotein W in rat 
muscle is non-detectable until selenium supplementation increased to 0.06 ppm, and 
the level of selenoprotein W in muscle reached a plateau at  1 ppm selenium 
supplementation where no further increase occurred. Except brain, selenoprotein W 
was higher in all tissues in sheep fed a selenium supplemented diet than in those fed 
the deficient diet. However, selenoprotein W levels were not different in brains 
between selenium-deficient and selenium-supplemented sheep. In contrast to rats, 
selenoprotein W was as high in the heart as in the muscle of selenium-supplemented 
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In the study with L8 muscle cells, selenoprotein W did not change significantly 
during cell differentiation, indicating that selenoprotein W was not affected by muscle 
cell differentiation. Selenite was the most effective form of selenium for selenoprotein 
W synthesis in these muscle cells. Selenoprotein W level reached a plateau when L8 
myotubes were incubated with 10-7 M selenium, whereas selenoprotein W mRNA 
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CHAPTER 1 
INTRODUCTION 
Until 1957, the only physiological significance of selenium was thought to be its 
toxicity. When selenium was shown to prevent dietary liver necrosis in rats (Schwarz and 
Foltz, 1957), this resulted in a reassessment of this element. Interestingly, that same year 
the properties of a newly discovered enzyme, glutathione peroxidase (GSH-Px) were 
reported (Mills, 1957). He found that this enzyme would protect hemoglobin against 
oxidative breakdown. However, it took a decade and a half to discover that GSH-Px had 
a relationship to selenium, namely that it is a selenoenzyme (Rotruck et al., 1973). This 
selenoenzyme, which was later termed cellular GSH-Px (cGSH-Px), was the first of a 
family of selenoenzymes to be discovered.  It was more than 10 years later when it was 
realized that the plasma GSH-Px was a different gene product (Takahashi et al, 1987). 
About the same time, the third member of this family, phospholipid hydroperoxidase 
GSH-Px, was discovered (Ursini et al, 1985). The latest one of this family, GI-tract 
specific GSH-Px, was discovered about two years ago.  It was found predominantly in 
the intestinal mucosa (Chu et al, 1993). The functions of these GSH-Pxs are to convert 
the damaging peroxides (organic and inorganic) to the less harmful alcohols. 
The sole relationship of selenium to GSH-Pxs was broken down when evidence 
was presented that this element was required for the activity of type I iodothyronine 2 
deiodinase (Arthur et al, 1990a). This was confirmed to be a selenoenzyme the following 
year (Berry et al, 1991). This provided a link between iodine and selenium metabolism. 
Recently, type III iodothyronine deiodinase was also recognized to be a selenoenzyme 
(Croteau et al., 1995). 
In the early research with selenium, it was realized that there was a metabolic 
relationship of this element to vitamin E (Hoekstra, 1975).  There was considerable 
debate on the essentiality of selenium in the 1960s because vitamin E appeared to fulfill 
most of the functions of selenium. However, with the demonstration of selenium as a 
requirement for the activity of enzymes, this left no doubt of its essentiality.  Selenium 
deficiency results in white muscle disease in lambs and calves, liver necrosis in rats, 
hepatosis dietetica (also called mulberry disease) in pigs, exudative diathesis in chicks and 
myopathy of the gizzard in turkey poults (Ullrey et al, 1983). The selenium requirements 
for animals are about 0.1 mg per kg diet. However, some animals such as turkeys appear 
to have a higher requirement and 0.3 mg selenium per kg diet are recommended. 
Selenium is also important in human health. A severe nutritional deficiency in 
discrete regions of China was found to be associated with an endemic juvenile 
cardiomyopathy disorder called Keshan disease (Chen et al, 1980). This problem was in 
villages where the residents grew all of their food. The soil in these areas is deficient in 
selenium and thus when vegetables are grown in these areas they do not contain enough 
selenium to protect against deficiency.  In the United States it was shown that muscle 
weakness could be prevented by selenium supplementation in patients on long-term 
parenteral nutrition (Brown et al, 1986). Therefore, selenium is definitely essential for 
optimum human health. 3 
Even though selenium was once thought to be a carcinogenic element, it is now 
recognized to have anticarcinogenic properties (Whanger, 1992).  Interest grew on this 
relationship when epidemiological studies suggested an inverse relationship between the 
incidence of certain- cancers in humans and the selenium content of soil in these areas 
(Combs and Combs, 1986). Subsequently, work with laboratory animals indicated that 
selenium would counteract to various degrees the carcinogenic effects of a number of 
chemicals. Now, there is intense interest in the relationship of selenium to cancers in 
humans, and the preliminary results look encouraging. After supplementation with 
selenium and vitamins A & E in Chinese subjects for 5 years, there has been a significant 
reduction in the incidence of stomach and throat cancer (Blot et al, 1993).  There is 
currently a study in the United States where the influence of selenium on colon cancer is 
under investigation (Clark, University of Arizona). Although, none of the results have 
been published, preliminary information indicate a positive effect of selenium on this 
disorder in humans. Therefore, selenium is a very unique element in that it has come full 
circle in two aspects--from a toxic element to an essential one and secondly from a 
carcinogen to an anticarcinogen. 
Another interesting characteristic of selenium is that it can counteract the toxicities 
of some heavy metals (Whanger, 1985; 1992). This rather unusual feature of an element 
such as selenium which is highly toxic itself at elevated levels counteracting the toxicity 
of heavy metals stimulated much interest in the relationship of this element to other 
elements.  Selenium appears to be very effective in counteracting the toxicities of 
mercury, thallium and cadmium, but less effective against silver and lead. 4 
Like any other essential element, selenium can be very toxic at elevated levels. 
The toxic nature of selenium compounds remained mostly a laboratory curiosity until the 
1930s when it was discovered that selenium was the active principle in forages and grains 
that caused alkali disease in livestock raised in certain areas of the American great plains 
(Ullrey et al, 1983). Three distinct forms of selenium poisoning have been described in 
livestock.  Acute poisoning is caused by the ingestion of a large quantity of highly 
seleniferous accumulator plants in a short period of time. The most common characteristic 
sign of acute selenosis is a "garlic breath" before sudden death. Chronic selenosis, of the 
blind staggers type, occurs in animals that consume a limited amount of selenium 
accumulator plants over a period of several weeks. The affected animals have impaired 
vision, wander, stumble and finally succumb to respiratory failure. Third, chronic 
selenosis, of the alkali-disease type, is the result of animals consuming high selenium feed 
over a period of many months. Signs of this disorder include liver necrosis, lameness, 
hoof malformations, loss of hair, and emaciation.  Although they have been studied 
extensively there have not been any health problems identified with selenium in those 
individuals living in high selenium areas of the world, except for some residents living 
in certain areas of Enshi county, Hubei Province, China. The soil in this area of China 
is naturally high in this element and the consumption of food in these areas contain 
enough selenium to cause toxicity problems. The signs of selenosis in humans include hair 
loss, abnormal finger and toe nails, loss of nails and skin lesions (Yang and Zhou, 1994). 5 
SELENOPROTEINS  
Under physiological conditions, selenium can be incorporated into several proteins 
either specifically or non-specifically. A group of selenium-containing proteins has 
received much attention recently. This group of proteins, called selenoproteins, contain 
selenium in the form of selenocysteine in their active sites and thus is selenium-dependent. 
Selenium was first found in protein A component of glycine reductase complex of 
Clostridium sticklandii (Turner and Stadtman, 1973). Subsequently, several selenoproteins 
were identified in both prokaryotes and eukaryotes, including formate dehydrogenases 
(Jones and Stadtman, 1981; Zinoni et al., 1986) and hydrogenase (Yamazaki, 1982), the 
glutathione peroxidase family (Rotruck et al.,  1973; Takahashi and Cohen, 1986; 
Schuckeil et al., 1991; Chu et al., 1993), type I iodothyronine 5'-deiodinase (Behne et 
al., 1990), type III iodothyronine 5-deiodinase (Croteau et al., 1995), selenoprotein P 
(Yang et al., 1987), selenoprotein W (Vendeland et al., 1993) and mitochondrial capsule 
selenoprotein (Karimpour et al., 1992). Although several selenoenzymes have been 
characterized, there are also some mammalian selenoproteins without a known function 
that have been studied. The three most studied ones are selenoprotein P, mitochondrial 
capsule selenoprotein, and selenoprotein W, the one studied in the Oregon laboratory. 6 
Prokaryotic Selenoproteins 
Selenoprotein A 
Selenoprotein A in glycine reductase of Clostridium is a small, acidic, heat-stable 
glycoprotein which contains selenium in the form of a selenocysteine (Cone et al., 1976; 
Turner and Stadtman, 1973). This selenoprotein had been cloned, sequenced and 
expressed in bacteria. The gene encoding selenoprotein A contains an in-frame TGA 
codon which codes for selenocysteine. The oxidized form of this protein, which is a 
dimer, can be converted to biologically active form (reduced form) by treatment with 
dithiothreitol or borohybride. This selenoprotein may serve as the immediate reductant 
in the reduction of glycine to acetate and ammonia (Garcia and Stadtman, 1992; 
Stadtman, 1990). 
Formate dehydrogenases 
Formate dehydrogenases are present in various methane-producing bacteria that 
utilize formate as a sole fermentable substrate. The approximate molecular weight of 
selenocysteine-containing subunit in formate dehydrogenase from Methanococcus vannielii 
is 100 KD. Formate dehydrogenase is extremely sensitive to the molecular oxygen. It is 
involved in gas formation and delivery the electrons from formate to nitrate reductase 
(Jones and Stadtman, 1981). 7 
Hydrogenases 
A hydrogenase isolated from Methanococcus vannielii was the first one found that 
contains selenium as selenocysteine (Yamazaki, 1982). It is a 340 KD selenoenzyme that 
contains 3.8 gram atoms of selenium as selenocysteine residues in four 13-subunits and is 
involved in transfer of molecular hydrogen. Some of the hydrogenases found in different 
bacteria also contain selenium in their amino acid sequences. However, the forms of 
selenium in these hydrogenases have not been identified yet. 
Other prokaryotic selenoproteins 
Nicotinic acid hydroxylase, xanthine dehydrogenase and thiolase are the other 
selenium-containing enzymes found in bacteria, but the form of selenium in these 
selenoenzymes is not selenocysteine (Axley and Stadtman, 1989). 
Eukaryotic Selenoproteins 
Glutathione peroxidase family. Glutathione peroxidase family includes at least four 
different peroxidases  cellular glutathione peroxidase, plasma glutathione peroxidase, 
phospholipid hydroperoxidase glutathione peroxidase and GI-tract specific glutathione 
peroxidase. 
Cellular glutathione peroxidase (cGSH-Px) 
Cellular glutathione peroxidase (cGSH-Px) was the first mammalian selenoprotein 
found in animals (Rotruck et al., 1973). cGSH-Px is present in most tissues, espectially 8 
high in liver and erythrocyte, but its tissue distribution varies from species to species. It 
is a tetramer composed of four identical 22-KD subunits and each subunit contains one 
selenocysteine. The function of cGSH-Px is to catalyze the reduction of hydrogen 
peroxide, organic hydroperoxide and fatty acid hydroperoxides using glutathione as a 
cofactor. It can protect animals from hemolysis. 
Plasma glutathione peroxidase (eGSH-Px) 
Plasma glutathione peroxidase (eGSH-Px) was purified from human plasma 
(Takahashi and Cohen, 1986). It is a glycoprotein and a tetramer composed of four 
identical 23-KD subunits and each subunit contains one selenocysteine. eGSH-Px has been 
found in human and rodent plasma, but its mRNA is not expressed in rodent liver. The 
exact function of eGSH-Px is still unclear. It may also metabolize hydrogen peroxide and 
fatty acid hydroperoxides as cGSH-Px does. Since the concentration of glutathione in 
extracellular fluid is very low, eGSH-Px may have functions other than a glutathione 
peroxidase. 
Phospholipid hydroperoxidase glutathione peroxidase (phGSH-Px) 
Phospholipid hydroperoxide glutathione peroxidase (phGSH-Px) was purified from 
porcine heart and liver (Schuckelt et al., 1991). It is a monomer with 20-KD molecular 
weight and contains one selenocysteine. phGSH-Px exists in several tissues but is highest 
in testis. The function of this GSH-Px is to reduce linoleic acid hydroperoxide and fatty 
acid hydroperoxides esterified to phospholipids, and therefore protects animals against 
lipid peroxidation. 9 
GI-tract specific glutathione peroxidase (GSH-Px-GI) 
The newest member of GSH-Px family is GI tract-specific glutathione peroxidase 
(GSH-Px-GI) which appears to be the major glutathione-dependent peroxidase in rodent 
GI tract (Chu et al.,-1993). It is a cytosolic protein and a tetramer composed of four 22-
KD subunits. Its mRNA also exists in human liver and colon, but only exists in rodent 
GI tract. The functions of GSH-Px-GI is assumed to be the same as those of cGSH-Px 
which catalyzes the reduction of hydrogen peroxide, linoleic acid hydroperoxide, tert-
bytyl hydroperoxide and cumene hydroperoxide. This enzyme appears to protect animals 
from toxicity of ingested lipid hydroperoxides. 
Type I iodothyronine 5'-deiodinase (5'-DI) 
Type I iodothyronine 5 '-deiodinase (5' -DI) is present mainly in the endoplasmic 
reticulum of liver and kidney (Behne et al., 1990). It is a homodimer composed of two 
27-KD subunits and each subunit contains one selenocysteine which is required for 
maximal enzyme activity. The function of 5'-DI is to convert thyroxine (T4) to the 
biologically active triiodothyronine (T3) and to regulate thyroid hormones. Selenium 
deficiency results in the increase of plasma T4 levels, due to the decrease of 5'-deiodinase 
activity. Since plasma T3 only decreased slightly in selenium deficiency, selenium-
deficient animals remained euthyroid (Beckett et al., 1987). 
Type III iodothyronine 5-deiodinase 
This enzyme was recently found to contain selenocysteine in its amino acid 
sequence. It acts as a 5-deiodinase to metabolize the active thyroid hormine,  thyroxine 10 
and 3, 5, 3'-triiodothyronine, to inactive metabolites, 3, 3', 5'-triiodothyronine (reverse 
T3) and 3, 3'-diiodothyronine (T2). Recently, a cDNA was found to encode this enzyme 
which contains an in-frame TGA codon that coded for selenocysteine at the active site 
(Croteau et al., 1995). This selenoenzyme is highly expressed in mammalian placenta and 
several fetal tissues. In addition, it is maintained at normal levels in brain, placenta and 
skin of selenium-deficient rats. The type III iodothyronine deiodinase plays a protective 
role in preventing over-exposure of tissues to excessive levels of active thyroid hormones, 
thus it is critical to thyroid hormone homeostasis in thyroid gland (St. Germain, 1994). 
Selenoprotein P (Se-P) 
Selenoprotein P (Se-P) is secreted by liver into plasma and turns over rapidly 
(Yang et al., 1987). In rats and humans, Se-P contains about 65% of plasma selenium. 
Se-P is  a glycoprotein with 57-KD molecular weight and  it  contains multiple 
selenocysteine residues. mRNA of Se-P was detected in several tissues, suggesting that 
it might be synthesized in other tissues as well, but this protein was only found in plasma. 
The function of Se-P is unknown. Since a Se-P receptor was found in rats, Se-P was 
suspected to be a transport protein (Gomez and Tappel, 1989). However, due to the fast 
turnover rate,  it is unlikely that Se-P serves as a transport protein. Cysteine and 
selenocysteine, which are the amino acids expected to have redox roles, are conserved 
to a very high degree from rat Se-P to human Se-P. Thus this selenoprotein may have an 
electron transfer function and also may function as a free radical scavenger (Hill et al., 
1993). Selenoprotein P is the most studied selenoprotein without a known function and 
selenium status has been shown to affect its concentrations (Yang et al, 1989). 11 
Selenoprotein W (Se-W) 
Evidence for a new selenoprotein  Selenoprotein W (Se-W) was found about 
twenty years ago, but had not been purified until recently (Vendeland et al., 1993). Se-W 
is a 10-KD cytosolic-protein which contains 1 g atom Se/mol as selenocysteine at position 
12 in the amino acid sequences. Glutamate, glycine, lysine, leucine and valine are the 
major amino acids in this protein. Tissue distribution of Se-W in rat indicates that it is 
present in muscle, brain, testis and spleen. This new selenoprotein appears to be 
selenium-dependent and selenium status of animals will affect its concentration in tissues 
(Vendeland et al, 1995). However, its characteristics and function remain unknown. 
Mitochondrial capsule selenoprotein 
Mitochondrial capsule selenoprotein (MCS) was found in the mid-piece region of 
mouse sperm in association with the mitochondria' helix (Calvin et al., 1981). It is a 
cysteine-rich protein and contains 3 selenocysteine per subunit. The cDNA encoding 
mouse MCS contains 3 in-frame UGA codons and the predicted molecular weight is 21.1 
KD (Karimpour et al, 1992). However, no information is available on its function. 
Other eukaryotic selenoproteins 
A 14-KD fatty acid binding protein from mouse liver was found to be a selenium-
binding protein, but the form of selenium in this protein remains unknown (Bansal et al., 
1989). There are evidences presented for other eukaryotic selenoproteins. However, no 
information is available on their characteristics (Behne et al., 1995; Hawkes et al., 1985; 
Whanger, 1987). 12 
CHARACTERISTICS OF SELENOPROTEINS 
Form of Selenium in Selenoproteins 
It has been reported that 92% of muscle selenium is protein-bound (Hawkes et al., 
1985). Several forms of selenium have been found in protein. They are selenocysteine, 
selenomethionine, selenotrisulfides and selenium-heavy metal complexes (Burk and Hill, 
1993). Selenocysteine-containing proteins are selenium-dependent and selenocysteine is 
specifically incorporated into proteins. Replacement of selenocysteine by cysteine or 
sulfur results in decrease or complete abolishment of enzymatic activity. Evidence 
suggests that animals can not distinguish between selenomethionine and methionine, 
therefore, selenomethionine can be incorporated into protein in place of methionine during 
protein synthesis. Incorporation of selenomethionine is non-specific and replacement of 
selenomethionine  by  methionine  does  not  appear  to  affect  protein  activity. 
Selenotrisulfides are mostly an in-vitro phenomenon and represent non-specific 
incorporation of selenium, and thus selenotrisulfide-containing proteins are unlikely to be 
of physiological importance. Selenium can form complexes with heavy metals, especially 
mercury. These complexes may serve to decrease toxicity of heavy metals in animals. 
There are other forms of selenium in proteins, but they are not selenium-dependent and 
their biological significance remain uncertain. 
More than 80% of whole body selenium was present as selenocysteine in protein 
when animals were given selenite, and less than 3% of whole body selenium was present 
as other forms of selenium in protein (Hawkes et al., 1985). Thus, selenocysteine appears 13 
to be the most important form of selenium in protein. All the selenoproteins found so far 
contain selenium in the form of selenocysteine in their amino acid sequence. 
Selenium-Dependent Regulation 
Selenoproteins can be differentially regulated by selenium and the regulation of 
individual selenoproteins occurs at different levels of selenium. An increase in selenium 
concentration would increase selenoprotein P concentration first, followed by increases 
in eGSH-Px and cGSH-Px (Burk and Hill, 1993). In selenium-deficieny, cGSH-Px 
decreases faster than 5'-deiodinase (Arthur et al., 1990b). The formation of most other 
selenoproteins has priority over that of eGSH-Px and cGSH-Px (Behne et al., 1995). The 
regulation of selenoprotein gene expression by selenium occurs primarily at the 
transcriptional level in prokaryotes, while the regulation occurs at various levels in 
eukaryotes. 
Novel In-Frame UGA Codon 
UGA is one of the stop codons which is used in translation of mRNA. By 
comparing portions of genes encoding selenoproteins, it was found that the position of a 
TGA, which corresponds to UGA in mRNA, was occupied by a selenocysteine residue 
in amino acid sequence. Therefore, it implied that the UGA codon was not a normal 
nonsense codon but was involved in the insertion of selenocysteine (Bock et al., 1991b). 14 
Berry and colleagues constructed different deletions and frame-shift mutants of 
type 1 5' deiodinase cDNA (Berry et al., 1991a). Plasmid DNA of these mutants was 
transcribed in vitro. The resulting RNA was injected into Xenopus oocytes and oocyte 
homogenates were assayed for their ability to deiodinate 3, 3', 5' -triiodothyronine (rT3). 
They found that the frame-shift mutant and mutants deleted sequence downstream of TGA 
resulted in complete lose of deiodinase activity in oocytes. These results indicated that the 
UGA codon for selenocysteine insertion was an in-frame UGA codon and sequence 
downstream of TGA was required for deiodinase activity. 
They also generated UGA codon mutants by site-directed mutagenesis and 
examined the deiodinase activities of these mutants in oocytes. When the UGA codon was 
mutated to UAA (stop codon) or UUA (codon for leucine), deiodinase activity in oocytes 
was completely lost. The UGA codon mutated to UGU (codon for cysteine) retained only 
10 % of deiodinase activity in oocytes. In the study using formate dehydrogenase gene 
from E. coli (Zinoni et al., 1987), 75Se incorporation was found to be completely 
abolished when the UGA codon was converted to UCA (codon for serine), but 75Se 
incorporation was decreased to about 10 % when the UGA codon was converted to 
cysteine codon (UGC or UGU). These results indicated that the UGA codon directed the 
incorporation of selenium in the form of selenocysteine which was required for maximal 
enzyme activity of the deiodinase. 
Comparison between the predicted secondary structures around the 5 ' -DI and 
GSH-Px UGA codons and in the coding region of Se-P shows no common features in 
UGA codon context. This suggests that there is no stringent requirement for a particular 
environment for UGA codon translation. To examine the role of UGA codon environment 15 
or context on the efficiency of selenocysteine incorporation, site-directed mutagenesis was 
used to introduce UGA codons into the rat 5'-DI coding sequence (Berry et al., 1993). 
Several mutations were constructed by converting cysteine codon to UGA codon in the 
wild-type coding sequence and also converted the wild-type UGA codon to a cysteine 
codon and introduced a UGA in an 'out-of-context' position. These mutant constructs 
were used to transfect COS-7 cells and translation of UGA codons was assessed by 
affinity labelling of [125I]BrAcT3, which was a substrate analog of T3, in COS-7 cell 
homogenates following transient expression. All constructs containing a single 'out-of-
context' UGA codon produced BrAcT3-labelled proteins of the same size as the wild-type 
protein, but constructs without SECIS (selenocysteine-insertion sequence) motif did not 
produce detectable BrAcT3-labelled proteins. In addition, translation of constructs 
containing two UGA codons are more difficult than those containing a single UGA codon. 
Except translational efficiency, expression of deiodinase activity was also assayed in cell 
homogenates transfected with these mutants. Only the full-length UGA mutant construct 
produced deiodinase activity comparable to the wild-type enzyme, and the deiodinase 
activity produced by all other mutants was lower than that produced by the wild-type 
enzyme. These results indicate that a specific UGA codon context is not required for 
efficient selenocysteine incorporation in eukaryotes. 
Selenium-Dependent Cotranslational Insertion of Selenocysteine 
A UGA codon was demonstrated to direct the insertion of selenocysteine in 
selenoproteins. The selenium-dependency of this incorporation was demonstrated by 16 
Zinoni and his coworkers by using the formate dehydrogenase gene from E. coli (Zinoni 
et al., 1987). They constructed several fusion plasmids with different N-terminal of 
formate dehydrogenase gene (fdhF) fused to B-galactosidase gene (lacZ). E. coli were 
transfected with different fusion plasmids and tested for B-galactosidase activity in the 
medium with or without selenium. They found that translation of hybrid gene containing 
UGA codon was selenium-dependent, while translation of hybrid gene without a UGA 
codon did not depend on selenium status. However, transcription did not require selenium 
in both types of  hybrid genes. By site-directed mutagenesis, the UGA codon was 
converted to UGC or UGU (codon for cysteine), or UCA (codon for serine). Ability to 
incorporate 75Se was examined in those mutant plasmids. When the UGA codon was 
converted to sense codons, the selenium-dependency of formate dehydrogenase mRNA 
was relieved. In addition, 75Se incorporation can be inhibited by cycloheximide (Sunde 
and Hoekstra, 1980) and by nuclease treatment (Wilhelmsen et al., 1985). These results 
indicated that translation of UGA codon was selenium-dependent and this UGA codon 
cotranslationally directed the insertion of selenocysteine into formate dehydrogenase 
polypeptide chain. 
Sunde and Evenson investigated the origin of the skeleton of selenocysteine moiety 
by perfusing isolated rat liver with "C- or 3H-labeled amino acids (Sunde and Evenson, 
1987). Glutathione peroxidase (GSH-Px) was purified and the specific activity of 
selenocysteine in GSH-Px determined. They found that "C-serine perfusion labeled 
serine, glycine and selenocysteine in purified GSH-Px, but 3H- serine perfusion only 
labeled serine and selenocysteine. These results indicated that selenocysteine in GSH-Px 17 
is derived from serine which provides the carbon skeleton for the selenocysteine moiety 
in selenoprotein synthesis. 
Structures of Selenoprotein mRNAs 
Stem-loop structure of mRNA in prokaryotes 
The in-frame UGA codon of selenoprotein mRNA directs the incorporation of 
selenocysteine. Ability of how the ribosomal translation assembly can distinguish this 
special UGA codon of selenoprotein mRNA from the stop UGA codon in other mRNA 
species is still unknown. It seems most likely that the specific secondary structure of 
mRNA is involved. 
By using computer analysis, it was reported that there was a putative stem-loop 
structure located immediately downstream of UGA in formate dehydrogenase mRNA 
(Zinoni et al., 1990). Zinoni and his coworkers introduced several different deletions 
from the 3' end approaching to TGA of formate dehydrogenase gene (fdhF). These 
different truncated 5' segments of fdhF gene were fused in-frame to the lacZ reporter 
gene. B-galactosidase activity and 75Se incorporation were measured in fusion genes. They 
found that at least 40 bases of fdhF mRNA downstream of UGA codon, which 
corresponded to the putative stem-loop structure, was required for both B-galactosidase 
expression and 75Se incorporation. Thus this stem-loop structure immediately downstream 
of formate dehydrogenase mRNA is required for decoding UGA and for incorporation 
of selenocysteine into formate dehydrogenase from E. coli. However, similar secondary 
structures can also be formed in mRNAs coding for other selenoproteins. In addition, 18 
disruption of the stem or changes in single nucleotide on the loop abolish selenocysteine 
incorporation (Bock et al., 1991b). Thus, the stem-loop structure appears to interact with 
the ribosome directly or indirectly to mediate incorporation of selenocysteine. 
3' UTR, Stem-loop structure and SECIS motif of mRNA in eukaryotes 
In eukaryotes, a predicted stem-loop structure similar to the one in E. coli is not 
immediately adjacent to UGA codon but is located several hundreds of bases away from 
UGA codon in the 3' untranslated region (3' UTR) of type 1 5'-deiodinase (Berry et al., 
1991b). Berry and collegues generated several deletion mutants of rat 5' -DI cDNA. By 
using  site-directed  mutagenesis,  they also  mutated  the UGA codon (code for 
selenocysteine) into a cysteine codon and generated a mutant deleted of the 3' UTR of the 
cysteine mutant. These mutants were assayed for 5'-DI activity after transient transfection 
in COS-7 or JEG-3 cells. They found that mutants without 3' UTR did not express 
deiodinase activity and deletion of the same sequences did not affect the activity expressed 
by the cysteine mutants. This indicated that 3' UTR was required for selenocysteine 
incorporation only and not for cysteine. In order to identify which specific sequence is 
needed for selenocysteine incorporation, they generated different internal deletion mutants 
of 3' UTR and found that a specific 3' UTR segment of about 200 nucleotides (from 
nucleotide 1440 to 1615) was required for selenocysteine incorporation. In addition, two 
deletion mutants with reduced spacing between the coding region and the 3' UTR 
produced higher 5 ' -DI activity than the wild-type cDNA. This suggested that the spacing 
between  3' UTR and UGA codon influences  the efficiency of selenocysteine 
incorporation. To confirm that this sequence is required only at translation, mutant 19 
plasmids were transcribed in vitro and the resulting RNAs were injected into Xenopus 
oocytes. The relative 5'-DI activity produced was in parallel to that produced by 
transfection. Thus the reduced expression caused by 3' UTR mutants was due to impaired 
translation. This indicates that selenocysteine is cotranslationally incorporated into the 
polypeptide chain of selenoproteins. 
A predicted stem-loop structure of 5'-DI mRNA was found to be located in this 
required 200 nucleotides of 3' UTR segment. Berry and collegues constructed a hybrid 
mutant with coding region of rat 5'-DI mRNA and 3' UTR of rat glutathione peroxidase 
mRNA, and measured deiodinase activity of this mutants. Although the primary sequences 
between the 3' UTR of rat 5'-DI mRNA and that of rat glutathione peroxidase are 
different, the 3' UTR of rat glutathione peroxidase mRNA can substitute for the 3' UTR 
of rat 5' -DI mRNA in directing selenocysteine incorporation. In addition, computer 
analysis predict similar stem-loop structures in the 3' UTR of both rat 5'-DI mRNA and 
rat glutathione peroxidase mRNA, and limited mutations in these structures could 
decrease or block the translation of these selenoproteins. These results suggest that 
secondary structure of mRNA may be involved in translational regulation of UGA codon 
in mRNAs of selenoproteins. Thus, Berry and collegues generated several deletion 
mutants within the predicted stem-loop region of rat 5'-DI mRNA and measured their 
deiodinase activities. They found that a short sequence in 3' UTR, SECIS motif, of rat 
5'-DI mRNA was essential for successful translation of 5'-DI and possibly other 
eukaryotic selenoproteins both in vivo and in vitro. 
Sequence analysis of human cellular glutathione peroxidase (cGSH-Px) mRNA 
predict two possible stem-loop structures around the in-frame UGA codon (Shen et al., 20 
1993). One putative stem-loop structure, which is similar to those found in formate 
dehydrogenase mRNA of E. coli and other prokaryotic selenoproteins, is located in the 
open reading frame and lies immediately downstream of UGA codon. The other putative 
stem-loop structure; which is similar to the one found in rat 5' -DI mRNA, is located in 
the 3' UTR. Several mutants, in which different segments from the potential in-frame 
stem-loop structure were deleted, were used to transfect 75Se-labeled COS-1 cells and 
incorporation of selenocysteine into glutathione peroxidase was examined. None of the 
deletion mutants in in-frame stem-loop structure blocked the selenocysteine incorporation 
into glutathione peroxidase, but mutants with different deletions in potential stem-loop 
structure in 3' UTR completely blocked the selenocysteine incorporation into glutathione 
peroxidase. These results indicate that the stem-loop structure in open reading frame of 
cGSH-Px mRNA is not involved in selenocysteine incorporation, whereas the stem-loop 
structure in 3' UTR of cGSH-Px is required for selenocysteine incorporation. 
The sequences of the 3' UTR of mRNAs of different eukaryotic selenoproteins are 
not conserved except for the limited consensus sequences. By comparing the 3' UTR of 
cGSH-Px with that of 5'-DI, two 4-nucleotide sequences within the loop (UAAA in the 
first loop and UGAU in the second loop) were identical to those at the same positions 
within the SECIS motif in the 5'-DI mRNA. Mutants with deletions of either one of the 
two 4-nt sequences completely abolished the incorporation of selenocysteine. These results 
indicate that SECIS motif and part of the 3' UTR sequence are both necessary and 
sufficient for translational insertion of selenocysteine at UGA codon in mRNAs of 
eukaryotic selenoproteins. 21 
Selenoprotein P (Se-P) contains two functional SECIS motifs with each in one 
stem-loop structure in 3' UTR. Berry and collegues examined the two stem-loops of Se-P 
in combination and individually for their ability to confer 5'-DI expression by using the 
rat 5' -DI coding region as a reporter for translation of UGA as selenocysteine (Berry et 
al., 1993). They found that a segment consisting of both stem-loops and an additional 600 
nucleotides in 3' UTR of Se-P produced four-fold higher deiodinase activity than the rat 
5'-DI SECIS motif. Deletion of the last 600 nucleotides decreased deiodinase activity only 
slightly. The first Se-P stem-loop alone produced a three-fold higher deiodinase activity 
than the 5'-DI SECIS motif, while the second Se-P stem-loop alone produced comparable 
deiodinase activity to that of the rat 5'-DI. In addition, deletion of the 8 by loop from the 
second Se-P SECIS motif eliminated translation. These results indicate that one stem-loop 
is sufficient for translation of multiple UGA codons and translation of multiple UGA 
codons does not require a Se-P SECIS motif, but can be directed by the 5'-DI SECIS 
motif. The relation of stem-loop and SECIS motif to each other is not the same in all 
mRNAs of eukaryotic selenoproteins, and this suggests that the mechanism by which the 
3' UTR mediates selenocysteine incorporation by UGA codon is complex. Stop codon 
function at 'out-of-context' UGA codons is suppressed by the SECIS motif in 3' UTR of 
eukaryotic mRNA, and hence the presence of a SECIS motif in eukaryotic selenoprotein 
mRNA relieves the necessity for stem-loop structures in the coding region which is a 
required characteristic of prokaryotic selenoprotein mRNAs, and permits complete amino 
acid sequence flexibility in UGA codon position (Berry et al., 1993). 
Comparison of stem-loop structures and sequences in 3' UTR of 5' -DI, GSH-Px 
and Se-P identified several conserved features: AAA in the loop region, an unpaired 22 
AUGA in the 5' arm of the stem and an unpaired UGR in the 3' arm of the stem. In 
addition, the distance between these unpaired bases and the loops, which are 10-12 bases, 
is highly conserved. Site-directed mutagenesis of three conserved A residues, the 3' 
unpaired UGR and 5' unpaired AUGA indicate that the three conserved A residues in the 
stem-loop of SECIS motif are optimal for selenocysteine incorporation and the unpaired 
conserved nucleotides in the stem are critical for SECIS function. This indicates that 
multiple contact sites are required for SECIS function. In addition, the SECIS motif is 
predicted to form stem-loops with high negative free energy. Disruption of particular 
secondary structure in the rat 5'-DI SECIS motif results in loss of activity, while restoring 
the secondary structure in SECIS motif restores full activity. Thus, the secondary 
structure in SECIS motif is also important in selenocysteine incorporation (Berry et al., 
1993). 
Berry and collegues constructed several mutants containing 'out-of context' UGA 
codons in the rat 5'-DI coding sequence, and these mutant constructs were used to 
transfect COS-7 cells and measured deiodinase activity. They found that the deiodinase 
activity was significatly higher with the 5'-DI SECIS motif present than it was for the 
SECIS deletion constructs in 'out-of context' mutants, and substitution of the Se-P SECIS 
motif increased deiodinase activity up to 4-fold compared with the 5 '-DI SECIS motif. 
In addition, they introduced the rat 5'-DI SECIS motif in different positions relative to 
the coding region and examined the effects of  different SECIS positions on 
selenocysteine incorporation. When the coding regions were separated by inserting an 
additional 'spacer' DNA, expression of deiodinase activity was comparable to the wild-
type enzyme. When the 5'-DI SECIS motif was in the 5' end of coding sequence or in 23 
trans position, the expression efficiency was much lower than that of the wild-type and 
the expression of SECIS motif in trans was in a dose-dependent fashion. To prove that 
this is only involved in translation, corresponding RNAs were transcribed in vitro and 
injected into Xenopus oocytes followed by assay of deiodinase activity in oocyte 
homogenates. This result was in similar to that by transfection (Berry et al., 1993). 24 
MECHANISM OF SELENOPROTEIN SYNTHESIS  
Prokaryotic Selenoprotein Synthesis 
Selenium-deficient E. coli mutants were used to study selenium incorporation into 
formate dehydrogenases. Four different genes, selA, selB, selC and selD, were identified 
to be required for selenoprotein synthesis and selenocysteine incorporation in prokaryotes 
(Leinfelder et al., 1988). 
selA gene encodes a selenocysteine synthase which is a pyridoxyl 5-phosphate 
enzyme and a 600-KD homodimer composed of two 50-KD subunits. Selenocysteine 
synthase is responsible for the correct aminoacylation of tRNA(') with selenocysteine and 
thus have a proofreading function. 
selB gene encodes a elongation factor (SELB) whose function is similar to that of 
the elongation factor, EF-Tu, which serves for all other amino acid-tRNAs. SELB is a 
GTP-binding protein and is sensitive to the length of the aminoacyl-acceptor helix, which 
appears to be a major recognition determinant (Baron and Bock, 1991). It has a 43-KD 
region at the N-terminal which is similar to EF-Tu, and an additional 25-KD region which 
functions  to recognize selenocysteyl-tRNA('). SELB binds stoichiometrically  to 
selenocysteyl-tRNA(') but not seryl-tRNA(s")  , while EF-Tu shows very low affinity for 
tRNA('), irrespective of whether it is charged with serine or selenocysteine. These results 
suggest that SELB has a function in the decoding process at the ribosome and specifically 
recognizes the aminoacyl residue of tRNA('). 25 
seiC gene encodes a specific tRNA(sc-c) which is required for selenoprotein 
synthesis in E. coli. This tRNA(sec) differs from other tRNAs which are used for other 
amino acids in length (95 bases versus 76 bases), D-loop (22 bases versus 10 bases), 
amino acid acceptor stem (8 by versus 7 bp) and several deviations from consensus 
nucleotides usually found in E. coli tRNAs. This special tRNA(') carries the anticodon 
sequence (UCA) for UGA and can be charged by L-serine. 
selD gene encodes an enzyme (SELD) which catalyzes the production of 
selenophosphate compound which is required for selenocysteine synthesis and for the 
conversion of the 5- methyl- aminomethyl -2- thio uridine into 5-methylamino-methy1-2-
seleno-uridine of tRNA('') and tRNA"s) species (Leinfelder et al., 1990). 
The mechanism responsible for selenoprotein synthesis is understood better in 
prokaryotic systems. Specific tRNA(') encoded by seiC gene is charged with L-serine, 
which is converted to seryl-tRNA(sec) by seryl-tRNA ligase. Selenocysteine synthase 
encoded by selA gene can discriminate parts of this tRNA(s") molecule and recognize the 
seryl moiety of seryl-tRNA('). After binding to seryl-tRNA('), selenocysteine synthase 
converts seryl-tRNA(s") to selenocysteyl-tRNA(scc) by catalyzing the 2,3-elimination of a 
H2O molecule from the seryl-residue. This results in the formation of an aminoacrylyl-
tRNA(s") intermediate which is bound to pyridoxal-phosphate via an aldimine linkage 
(Forchhammer and &lock, 1991). H2Se is added subsequently to the double bond of the 
aminoacrylyl residue which results in the replacement of the side-chain oxygen in serine 
by selenium to yield selenocysteine. SELD, which is required for the addition of H2Se 
to the aminoacrylyl double bond, catalyzes the production of selenophosphate compound 
from selenide. This step requires ATP which is hydrolyzed during this process. The 26 
selenocysteyl-tRNA(see) is then released from selenocysteine synthase and becomes bound 
by SELB elongation factor which is encoded by selB gene. SELB forms a ternary 
complex with selenocysteyl-tRNA(') and GTP, which in turn attaches to the stem-loop 
immediately downstream of UGA in the open reading frame of mRNA. This facilitates 
the incorporation of selenocysteine into polypeptide chain of selenoprotein, probably 
either by bringing the selenocysteyl-tRNA(') closer to the UGA codon or by blocking the 
access of release factor 2 to A site on ribosome where it acts to terminate translation of 
mRNAs (Bock et al.,  1991b). Although sequences upstream of  UGA codon in 
prokaryotic selenoprotein mRNA are not required for specificity of selenocysteine 
incorporation, they may be involved in the modulation of the efficiency of this process. 
Eukaryotic Selenoprotein Synthesis 
The use of UGA as a selenocysteine codon occurs in both prokaryotes and 
eukaryotes, but the mechanism of recognition differs between these two types of 
organisms. Much less imformation is available on biochemistry of selenoprotein synthesis 
in eukaryotes. However, there are several features of eukaryotes which are similar to that 
of prokaryotic selenoprotein synthesis. 
It has been reported that the incorporation of selenocysteine was mediated by a 
selenocysteine-specific tRNA (Hawkes et al., 1982). Hawkes and his coworkers studied 
the aminoacylation of rat liver tRNA with selenocysteine in tissue slices and in a cell-free 
system by using [75Se]selenocysteine and [75Se]selenite as substrates (Hawkes et al., 
1982). They found that [75Se]selenocysteine was specifically associated with selenocysteyl-27 
tRNA via an aminoacyl linkage and this specific aminoacylation was resistant to 
competition by excess of either unlabeled cysteine or a mixture of the other 19 amino 
acids in the cell-free selenocysteine aminoacylation system. This specific tRNA(sec) can 
carry selenocysteine in vivo and is similar to tRNA(see) in E. coli. It carries an anticodon 
for UGA and can be charged with L-serine in a manner similar to that in E. coli 
tRNA(sec). In addition, [75Se]selenocysteyl-tRNA(') was purified from rat mammary tumor 
cells and used in E. coli  ribosomal binding studies. Most of the 'Se is attached to 
selenocysteyl-tRNA(') which recognizes UGA codon only, but not any of the other 
codons. Thus, this selenocysteyl-tRNA(') appears to function both as a carrier for 
selenocysteine synthesis and as selenocysteine donor in response to specific UGA codon 
(Lee et al., 1989). 
In addition to the specific tRNA(see) for selenocysteine, the special in-frame UGA 
codon is used for coding selenocysteine in eukaryotic mRNAs. Stable stem-loop structures 
are located in 3' UTR of all eukaryotic selenoprotein mRNA for decoding UGA codon. 
SECIS motif, a short sequence in 3' UTR of eukaryotic selenoprotein mRNA is also 
required for directing selenocysteine insertion at UGA codon. 
The mechanism responsible for selenocysteine synthesis and its incorporation in 
eulcaryotes is only partial characterized. The specific tRNA(sec) ,which carries the 
anticodon for UGA, is charged with serine and seryl-tRNA(s") is formed by seryl-tRNA 
ligase. The mechanism of conversion of seryl-tRNA(') to selenocysteyl-tRNA(') has not 
been established yet. Recent evidence suggests that enzymes analogous to selenocysteine 
synthase and SELD in prokaryotes also exist in mice (Mizutani et al., 1992). Therefore, 
these enzymes may catalyze the production of required seleno-compounds from selenium 28 
presursors and the conversion of serine to selenocysteine, to form selenocysteyl-tRNA('). 
In addition to seryl-tRNA(s") and selenocysteyl-tRNA(s"), phosphoseryl-tRNA(') has been 
isolated. Phosphoseryl-tRNA(') can be converted to selenocysteyl-tRNA(') in vitro, thus 
this tRNA species may compete with selenocysteine synthase and serve as an intermediate 
in selenoprotein synthesis (Lee et al., 1989). However, there is no evidence to indicate 
that seryl-tRNA( sec) can be converted to phosphoseryl-tRNA('). The mechanism of how 
the selenocysteyl-tRNA(') interacts with mRNA of eukaryotic selenoprotein is still 
unknown. There may be a translational elongation factor similar to the one in prokaryotes 
which is involved in the association of selenocysteyl-tRNA(s") with mRNA. Furthermore, 
the stem-loop structures in 3' UTR of mRNA may interact with the translational 
machinery (selenocysteyl-tRNA('), elongation factors and other factors) and possibly with 
RNA structures or the nascent protein. This complex would then allow translation of 
UGA codons in the adjacent coding region, without a strict requirement for the UGA 
codons to be in a particular environment, and specifically direct selenocysteine 
incorporation probably by pausing the ribosomes when they approch the UGA codon to 
allow time for binding of selenocysteyl-tRNA('). In addition, the stem-loop structure of 
eukaryotic mRNA is in the 3' UTR which is different from that of prokaryotic mRNA. 
The reasons for the different mechanisms responsible for eukaryotic selenoprotein 
synthesis as compared to prokaryotes may be the different location of stem-loop structures 
in selenoprotein mRNAs. 29 
Differences in Selenoprotein Synthesis Between Prokaryotes and Eukaryotes 
The mechanisms responsible for prokaryotic and eukaryotic selenoprotein synthesis 
are not completely understood. However, several features required for selenocysteine 
incorporation are different between prokaryotes and eukaryotes. The required stem-loop 
structure for selenocysteine insertion  is  located in coding sequence immediately 
downstream of UGA codon in prokaryotes, while it is located in 3' UTR with several 
hundred bases away from UGA codon in eukaryotes. The sequences upstream of UGA 
codon are not involved in incorporation of selenocysteine in prokaryotes, whereas they 
are involved in  selenocysteine incorporation in eukaryotes.  In addition, SECIS 
(selenocysteine-insertion sequence) motifs are required for directing of selenocysteine 
insertion in eukaryotes, while this SECIS motif is not found in prokaryotes. Thus, the 
mechanism responsible for selenoprotein synthesis in eukaryotes may be different and 
more complex from that for selenoprotein synthesis in prokaryotes. These differences may 
account for the failure of attempts to express eukaryotic selenoprotein mRNA in 
prokaryotic systems. 30 
GENERAL ASPECTS OF SELENOPROTEINS  
There are three stop codons used for termination in mRNA translation, which are 
UGA, UAA and UAG. The rat 5 `--DI coding sequence terminates with a UAG, while the 
human 5'-DI, rat GSH-Px, and rat and human selenoprotein P coding sequences all 
terminate with UAA. Therefore,  it appears that the translational machinery of 
selenoprotein specifies UGA as a selenocysteine codon by using stop codons other than 
UGA. However, the mechanism for recognization of appropriate UGA codons and 
distinguision of them from the UGAs used as stop codons is unclear. Selenium is 
incorporated specifically in amino acid tRNAs. In certain anaerobic bacteria and E. coli, 
glutamate- and lysine-accepting tRNAs are the species that contain the most conspicuous 
amounts of selenium. Selenium occurs in the wobble position of the anticodons of these 
seleno-tRNA in the form of a 5- methylaminomethyl- 2- selenouridine residue. The presence 
of selenium in the anticodons of glutamate- and lysine-accepting tRNAs appears to 
influence which codons prefer a particular amino acid. When the sulfur-modified uridine 
is present in the wobble position of the anticodons, the glutamate and lysine codons 
ending in A generally are preferred, but with the substitution of selenium, interaction with 
anticodons ending in G is facilitated. Such differential effects on codon-anticodon 
interactions may also be important in specifying synthesis of selenoproteins and in 
modulating rates of selenoprotein synthesis under various conditions (Stadtman, 1987). 
In addition, the UGA codon for selenocysteine has been conserved in all three lines of 
descent (Bock et al., 1991a). This suggests that it existed before bacteria, archaea and 
eukarya separated. Its higher susceptibility to oxidation or its extreme sensitivity to heavy 31 
metal ions may be the reasons that selenocysteine was selected and restricted to a few 
special proteins (Bock et al., 1991b). 
The translation of multiple UGA codons is more difficult than that of single UGA 
codon. Selenoprotein P mRNA contains 10 UGA codons, therefore the translation rate 
of this selenoprotein should be lower than that of other selenoproteins. However, the half-
life of selenoprotein P is very short. The mechanisms responsible for balancing between 
high turn-over rate and low synthesis rate of this selenoprotein P are not understood. It 
is possible that certain UGA codons are translated more efficiently than others because 
the ribosomal pauses occur at some positions more than at others. Thus, UGA codons of 
selenoprotein P may be translated more efficiently than that of other selenoproteins. In 
addition, some specific proteins have been reported to be involved in recognizing certain 
nucleotide sequences. Regulation of ferritin and transferrin receptor expression by iron 
response element-binding proteins is a good example of protein recognition of both base-
paired regions and specific unpaired nucleotides. Therefore, there may be some 
unidentified proteins or factors involved in eukaryotic selenoprotein synthesis. Probably 
some specific proteins or factors would specifically increase selenoprotein P synthesis but 
not other selenoproteins. 
Certain selenoproteins have priority for selenium when it is limited. The 
differences in efficiency of stem-loop function may allow the cellular translation 
machinery to express some selenoproteins preferentially over others. In fact, the relative 
efficiencies of the SECIS motifs in Se-P, 5'-DI and GSH-Px parallel their order of 
appearance upon selenium repletion in selenium-depleted animals (Hill et al., 1991). 32 
Selenoprotein P has multiple UGA codons in the coding region and two stem-loop 
structures in the 3' UTR of its mRNA. Thus, it can be used as a model protein to study 
the mechanism responsible for eukaryotic selenoprotein synthesis. However, the attempts 
to express selenoprotein P have not been successful so far. From the present analysis with 
selenoprotein P, it seems that a separate stem-loop structure is not required for translation 
of each UGA codon in mRNA. 
Knowledge of the detailed mechanism responsible for selenoprotein synthesis can 
apply to design and construct selenoproteins through selenocysteine insertion at selected 
positions. The selenoprotein engineering has several uses: (1) It may help to determine 
the location of cysteine residues involved in disulfide bridge formation using NMR 
analysis of the protein in solution. (2) The replacement of a single cysteine residue by 
selenocysteine may make such a protein amenable to X-ray analysis where specific heavy 
metal derivatives are unavailable. Two principal strategies can achieve this targeted 
insertion: (1) Change the particular codon into a UGA codon and alter the mRNA context 
to create the downstream stem-loop structure that possesses the sequence in the loop 
which is required for selenocysteine insertion. This strategy has already been carried-out 
successfully (Heider and Bock, 1992). (2) Change the specific tRNA(see) structure in a 
way that it can be recognized by elongation factor EF-Tu. The mutant tRNA(') variant 
with a 7-bp aminoacyl-acceptor helix should be an excellent candidate for the targeted 
insertion of selenocysteine (Beck et al., 1991). In addition, the ability to introduce a 
heavy metal into a specific site in proteins could prove to be a powerful aid to three-
dimensional structure studies. 33 
When animals are deficient in selenium, the first priority of body selenium is to 
supply selenium to the brain, and endocrine and reproductive organs, while the second 
priority is to supply selenium to heart, muscle and liver. However, in those tissues, 
selenium is mostly used to synthesize selenoproteins other than glutathione peroxidases 
(Behne et al., 1988). A study in rat tissues showed that only one-third of whole body 
selenium was used for synthesis of glutathione peroxidases and the remaining two-thirds 
of whole body selenuim was used for synthesis of other selenoproteins. Therefore, other 
selenoproteins may be critical for normal cellular metabolism (Hawk et al., 1985). 34 
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ABSTRACT 
Rabbits were immunized with two synthetic peptides based on hydrophilic regions 
of selenoprotein W from rat muscle. The resulting polyclonal antibodies were used in 
Western blots to determine the compartmentation and tissue distribution of selenoprotein 
W, and to determine the influence of selenium on the levels of this selenoprotein in rat 
muscle. Selenoprotein W exists mainly in cytosol but very small amounts were associated 
with membranes. Western blots revealed selenoprotein W in muscle, spleen, testis and 
brain of rats.  Rats were fed diets of either no addition of selenium (0 ppm Se) or 
additions of 0.1 and 4.0 micrograms selenium per gram (0.1 ppm Se and 4.0 ppm Se) 
diet for 6 weeks. Selenoprotein W was undetectable in skeletal muscle of rats fed the 
basal (selenium-deficient) diet, detectable in those fed 0.1 ppm selenium in the diet, and 
were much higher in muscle from rats fed 4 ppm selenium diet. In a species comparison, 
Western blots indicated the presence of selenoprotein W in muscle of rabbits, sheep and 
cattle. 42 
INTRODUCTION  
At present there are only two known mammalian selenoenzymes.  One is the 
selenium dependent glutathione peroxidase  (GSH-Px) family in which at least four 
members have been identified. The first recognized some 20 years ago was the cellular 
GSHPx (1).  It represented the only known biochemical function of selenium for many 
years and was used extensively to assess selenium nutritional status. This selenoenzyme 
(GSHPx-1) contains 4 g atoms of selenium per mole of protein (2, 3). A  GSHPx  was 
purified from plasma (GSHPx-p) and shown to be immunochemically distinct from the 
cellular  GSHPx (4).  Although it shares some sequence identity with  GSHPx-1, it is 
clearly a separate gene product (5).  Like  GSHPx-1 the  GSHPx-p consists of four 
identical subunits each of which contains one selenocysteine. A third  GSHPx  has been 
characterized in recent years (6).  It is a monomer which is similar to the subunits of the 
previous two  GSHPxs  and contains one selenocysteine.  It is capable of reducing fatty 
acid hydroperoxides esterified to phospholipids (7) and thus is identified as  PHGPX. 
Evidence was obtained for a fourth GSHPx found predominantly in the gastrointestinal 
tract (8), designated as GSHPx-GI.  The other known mammalian selenoenzyme is Type 
I iodothyronine 5'-deiodinase, which contains 1 g atom of selenium per mole protein (9, 
10). It converts thyroxine to triiodothyronine and thus provides a metabolic link between 
selenium and iodine. 
Selenoprotein P is the most studied selenoprotein without a known function.  Its 
existence has been known for over 15 years and the majority of the selenium in plasma 
of rats (11) and humans (12) has been shown to be associated with this protein. The 43 
cDNA for selenoprotein P has been cloned and sequenced (13). There are ten TGAs in 
the open reading frame, indicating that the protein contains ten selenocysteine residues 
in its primary structure.  The levels of this protein in the plasma are affected by the 
selenium status of the animal (14). The only other selenoprotein known to possess more 
than one selenocysteine per subunit is mitochondrial capsule selenoprotein (MCS) from 
mouse sperm which interestingly contains all three selenocysteines in the first 35 amino 
acids of a total of 197 residues (15).  Although evidence for a number of other 
selenoproteins has been presented (16, 17, 18), the properties of a small molecular weight 
protein, called selenoprotein W, from muscle were recently presented (19). The present 
report presents information on the tissue distribution and the effects of selenium status on 
tissue levels of this protein, an area where there is now no information. 44 
MATERIALS AND METHODS  
From the amino acid sequence of selenoprotein W (20) the hydrophilicity was 
calculated as described by Kyte and Doolittle (21).  The first hydrophilic center was 
located between amino acid residues 13 and 31 (see figure 2-1). A peptide based on these 
residues (NH2Cys-Gly-Tyr-Lys-Pro-Lys-Tyr-Leu-Glu-Leu-Lys-Glu-Lys-Leu-Glu-His-Glu-
Phe-Pro-Gly-COOH) was synthesized using Fmoc chemistry (22) by the Central Services 
Laboratory of the Center for Gene Research and Biotechnology at Oregon State 
University. The amino terminal cysteinyl residue, which is not part of the selenoprotein 
sequence, was included for conjugation of the peptide to a carrier protein. The peptide 
was conjugated through the cysteinyl sulfhydryl to maleimide activated keyhole limpet 
hemocyanin (22). Rabbits were immunized by injecting 250 ug conjugated peptide in 
Freund's adjuvant (complete adjuvant for the first injection and incomplete adjuvant for 
later injections) of this peptide at three week intervals for 9 weeks. Blood sample was 
taken one week after the last injection and the serum obtained by centrifugation at 1,000 
x g for 15 minutes. Polyclonal antibodies were purified from serum by sulfolink affinity 
columns (Pierce) coupled with the synthetic peptides. Antibodies were concentrated 
approximately ten fold relative to serum during purification and these preparations were 
used in the Western blot assays. 
Western blot assays were used to survey tissues from a male rat fed commercial 
rodent chow. The presence of selenoprotein W was tested in muscle, heart, plasma, 
erythrocytes, liver, kidney, spleen, lungs, intestinal mucosa, intestinal muscle, testis and 
brain. To determine the effect of selenium status on selenoprotein W levels, weanling 45 
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Figure  2-1. Graph of the calculation of the hydropathicity of selenoprotein W. 46 
male rats (4 weeks of age) were fed either the basal diet or this diet with additions of 
either 0.1 or 4.0 ppm selenium as selenite for 6 weeks. The basal diet was composed of 
30% torula yeast (Rhinelander Paper Co., Rhinelander, WI, USA), 51% sucrose, 9% 
purified cellulose (Solka Floc, Brown Co., Berlin, NH, USA), 5% corn oil, 3.5% AIN-
76 mineral mix without selenium and 1% AIN-76 vitamin mix (23), 0.3% DL-
methionine, and 0.2% choline citrate.  In all studies animals were anesthetized with 
sodium pentobarbital (80 mg/kg i.p.) and blood was taken via cardiac puncture. After 
the rats were decapitated while under anesthesia, the tissues were removed and frozen 
immediately afterwards at -70 °C. In the species survey, muscle samples were taken from 
adult female rabbits, sheep (wether) and cattle (steer) at the time of slaughter.  These 
animals had been fed commercial diets. The tissues were frozen at -70 °C until used. 
Cytosol and membrane fractions of rat muscle were separated according to the 
method of Farese et al (24). Muscle samples were homogenized in 6 volumes of buffer 
A (20 mM Tris, pH 7.5, 0.25 M sucrose, 1 mM EGTA, 5 mM EDTA, 1 mM PMSF, 
50 mM B-mercaptoethanol and 25 lig/mlleupeptin). The homogenate was centrifuged at 
100,000 x g for 20 min at 4 °C. After the supernatant (cytosol) was collected, the pellet 
was resuspended in buffer A containing 1% Trition X-100 and placed on ice for 30 min 
The pellet suspension was centrifuged at 100,000 x g for 20 min at 4 °C and the 
supernatant (membrane-bound proteins) was collected.  The other  tissues were 
homogenized in buffer A at ratio of 1 to 6.  Supernatants of 17,000 x g  10 min 
centrifugation were used in the assays. Protein content of cytosols and membrane-bound 
protein fractions (muscle) were determined by the Bradford dye-binding assay (25) using 
bovine serum albumin as standard. 47 
For Western  Blot  Analysis,  samples  (100  or  200  lig  protein)  were 
electrophoretically separated on 7.5 to 15% gradient SDS-polyacrylamide gels as 
described by Laemmli (26). Proteins in transfer buffer (25 mM Tris, 192 mM glycine 
and 20% methanol) at 4°C were transferred onto nitrocellulose membrane (0.2 ;.tm  BA-
83, Schleicher & Schuell) according to methods of Towbin et al (27).  After transfer, 
membranes were incubated with blocking solution (5% non-fat dried milk in TTBS 
[0.05% Tween 20 in TBS]) at 25°C for 1 hr, then incubated with rabbit anti-peptide 1 
polyclonal antibody (1:500 dilution) at 25°C for 1.5 hr. Following three washes, 
membranes were incubated with horse-radish peroxidase-conjugated goat anti-rabbit IgG 
antibody (Bio-Rad, Richmond, CA). Membranes were then washed four times with TTBS 
and specific bonding of anti-selenoprotein W antibody onto membrane was detected by 
ECL detection system (Amersham, Arlington Height, IL). The relative amounts of 
selenoprotein W present in the various samples were estimated by densitometric scanning 
of the X-ray film using a Model 1650 transmittance/reflectance scanning densitometer 
(Bio-Rad) and the Hoefer GS 350 Data System (Hoefer Scientific Instruments, San 
Francisco, CA). 48 
RESULTS  
As shown in Figure 2-1, two major hydrophilic regions in selenoprotein W are 
predicted by the Kyte and Doolittle algorithm. These are from amino acids 13 to 31 for 
peptide one, and from 51 to 69 for peptide two. Rabbits were immunized with peptides 
based on both regions, however, only antibodies to the first peptide (13 to 31) were used 
for the present studies because they were found to have higher titers and resulted in less 
background than those produced with antibodies to peptide two. 
Western blots of rat tissue preparations revealed the presence of selenoprotein W 
only in muscle, spleen, testis and brain (Figure 2-2). Based on densitometer readings, 
this protein was highest in the muscle and brain, and lower in spleen and testis.  It was 
not detected in liver, kidney, intestinal mucosa, intestinal muscle, lungs, heart, plasma 
and erythrocytes. 
Diets supplemented with 0.1 ppm selenium significantly increased the levels of 
selenoprotein W in muscle as compared to rats fed the deficient diet (Figure 2-3). The 
bands were undetectable in Western blots of 100 lig muscle cytosol protein from rats fed 
the 0.1 ppm selenium diet (data not shown). The muscle preparations from rats fed the 
4 ppm selenium diet contained much more selenoprotein W than muscle samples from the 
other two groups of rats. Using a standard curve of purified selenoprotein W, the mean 
concentration of selenoprotein W in rats fed 0.1 and 4 ppm selenium diets was calculated 
to be respectively 1.2 and 10.3 ng/mg protein. GSHPx activity and selenium content 
were low in muscle of the rats fed the deficient diet, confirming their low selenium status 
(data not shown). 49 
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Figure 2-2. Western blot of the tissues from rats fed commercial rat chow.  The 
preparations represent from left to right pure protein (10 ng) from rat muscle (PP), 
muscle (M), heart (H), liver (Li), lungs (Lu), spleen (Sp), kidney (K), testis (T), brain 
(B), intestine (I), intestinal mucosa (Im), serum (Ser) and erythrocytes (RBC).  Levels 
of 100 i_ig protein were used for each tissue. Ovalbumin (46 KD), carbonic anhydrase 
(30 KD), trypsin inhibitor (21.5 KD), lysozyme (14.3 KD), aprotinin (6.5 I(D) and 
insulin b chain (3.4 KD) were used as the molecular weight markers. 50 
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Figure 2-3. Effects of different levels of selenium on selenoprotein W in rat muscle. 
Lanes 1-6 are of muscle from rats fed diet with no added selenium; lanes 7-11 are of 
muscle from rats fed diet with 0.1 ppm Se and lanes 12-15 are of muscle from rats fed 
the diet with 4 ppm Se. An amount of 200 µg protein were used for all samples. Lane 
16 is 5 ng of purified selenoprotein W from rat muscle. The same molecular weight 
standards as noted in figure 2-2 were used. 51 
The antibody was shown to be specific for selenoprotein W by Western blot 
method (Figure 2-4). Although proteins of higher molecular weight produced a signal in 
the Western blot analysis, they did not interfere in the selenoprotein assay. The high 
molecular weight signals were artifacts produced by the secondary antibody. Omission 
of the primary antibody still produced the high molecular weight signal, but eliminated 
the selenoprotein W signal. Addition of synthetic peptide to the primary antibody solution 
before membrane incubation eliminated the selenoprotein W signal, but the high 
molecular weight signal was unaffected. As would be expected, the extraneous bands 
were not affected by the selenium status of the animal. 
Selenoprotein W was present mainly in the cytosol of the muscle (Figure 2-5A, 
lanes 1 and 2) but very little was associated with the membranes (Figure 2-5A, lane 3). 
Muscle samples from rabbit, sheep and cattle indicated the presence of this protein in 
these tissues (Figure 2-5B). Based on the densitometric reading, it appears to be present 
at higher concentrations in muscle from sheep, cattle and rabbits than in this tissue from 
the rat. 52 
Figure 2-4. The effects of primary and secondary antibodies on the signals in the_Western 
blots. Lane 1 is the standard purified selenoprotein W (10 ng) from rat muscle; lane 2 
is where the primary antibody (anti-peptide antibody) was omitted but the secondary 
antibody (goat anti-rabbit IgG antibody) was included; lane 3 is where the muscle cytosol 
was incubated with the primary antibody before application to the nitrocellulose 
membrane; lane 4 is where the primary antibody was incubated with the peptide before 
application to the nitrocellulose membrane; lane 5 is where both primary and secondary 
antibodies were included (the usual procedure); lane 6 is cytosol from the selenium 
supplemented rat; and lane 7 is the muscle cytosol from selenium deficient rat. 53 
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Figure 2-5. Western blots of muscle fractions from rats and of muscle cytosols from 
rabbits, sheep, cattle and rats. A: compartmentation of selenoprotein W in rat muscle. 
Lane 1: 100 lig protein from supernatant of muscle homogenate centrifuged at 17,000 xg 
for 10 mins. Lane 2: 100 j.tg protein from cytosol fraction of muscle homogenate 
centrifuged at 100,000 xg for 20 mins. Lane 3: 100 lig protein from membrane fraction 
of muscle homogenate. B: Western blot of selenoprotein W in muscle from different 
species.  Lane 1: partial pure selenoprotein W. Lanes 2, 3, 4, 5 and 6 are 100 i.tg 
cytosolic protein from muscles of sheep, cattle, rabbit, male rat and female rat, 
respectively. 54 
DISCUSSION  
The tissue distribution of selenoprotein W is peculiar and does not offer obvious 
suggestions regarding its function. The presence in muscle, spleen, testis and brain is 
intriguing but it is not obvious why just these tissues would contain this protein. The 
tissue distribution may differ between species. For example, based on 'Se incorporation 
selenoprotein W is assumed to be present in hearts of sheep (28). After injection with 
radioactive selenium, gel filtration  patterns of sheep heart cytosol indicated equal 
incorporation of selenium into selenoprotein W and GSHPx. This was confirmed by 
recent Western blots of heart preparations from sheep fed high levels of selenium in the 
diet. Selenoprotein W was almost as high in the heart as in muscle. The absence of this 
protein in rat heart was somewhat surprising but this may relate to the difference in 
selenium deficiency syndromes between species. Selenium deficiency results in cardiac 
damage in sheep (29) but not in rats (30).  Recent work with guinea pigs and sheep 
indicates the presence of selenoprotein W in a number of tissues, suggesting species 
differences on the tissue distribution of this selenoprotein. 
We have recently cloned cDNA for selenoprotein W. The unknown amino acids 
identified by Xs in Figure 2-1 are now known to be cysteine at positions 9, 32 and 36, 
serine at position 70 and lysine at position 71. Selenocysteine is at position number 12 
as identified by U in this figure. The final 10 amino acids (77-87) are threonine, alanine, 
isoleucine, lysine, alanine, alanine, leucine, alanine, glycine, cysteine and glycine. 
Examination of the amino acid sequence around the selenocysteine residues of GSH-Px-1 
from rat liver (31) or bovine erythrocytes (32), GSH-Px-P from human plasma (5) or rat 55 
plasma (33), PHGPX (6), GSH-Px-GI (8), type I iodothyronine 5' -deiodinase (34), MCS 
(15) and selenoprotein P (13) revealed no homology among them.  All except 
selenoprotein P have the selenocyteine residues in the early part of the molecule, which 
is similar to selenoprotein W. GSH-Px-1, GSH-Px-P, PHGPX and GSH-Px-GI have 
valine, alanine, and serine as the second, third and fourth amino acid before the 
selenocysteine residue, but this  is not the case for the other selenoenzymes or 
selenoproteins. A unique feature of MCS is the presence of a cysteine residue adjacent 
to all three selenocyteine residues (15). The unique features of selenoprotein P are that 
most of the selenocysteine residues are near the carboxyl end of the protein and there are 
seven histidines in a row in this protein (13). Selenoprotein W (Figure 2-1) is similar to 
MCS (15) in that there is a proline (third and fourth respective for MCS and 
selenoprotein W) near the selenocysteine residues.  It should be noted that in the earlier 
work tryptophan was mistakenly indicated to be present in selenoprotein W (19). Instead, 
this should have been tyrosine. 
Selenium status can affect tissue levels of this protein (Figure 2-3).  This is 
consistent with earlier studies in which radioactive selenium was used.  Gel filtration 
showed a lower molecular weight radioactive selenium containing peak in tissue 
preparations from sheep, rats and cattle (28, 35, 36).  In sheep, the level of the low 
molecular weight selenoprotein appeared to be affected by selenium status (28). 
Antibodies to a peptide from selenoprotein W detected the selenoprotein in muscle from 
sheep, rabbit and cattle (figure 2-5B). The immunological cross-reactivity implies that this 
protein may have highly homologous amino acid sequence among these species. In 
addition, the higher densitometric readings in sheep, cattle and rabbit suggest either that 56 
higher concentrations of homologous proteins exist in these species or that antibody 
affinity is higher against the homologous proteins. 
Selenium deficiency results in a muscular and cardiac degeneration in lambs and 
calves called White- Muscle Disease (29).  Likewise, a severe nutritional selenium 
deficiency in discrete regions of China was associated with an endemic juvenile 
cardiomyopathy disorder called Keshan disease (37). Muscle weakness has been shown 
to be prevented by selenium supplementation in patients on long term parenteral nutrition 
(38, 39). Therefore, there is sufficient evidence to indicate that selenium is important for 
normal muscle metabolism. Whether selenoprotein W has any significant role in muscle 
metabolism cannot be determined from the present work, but since it is present in muscle 
at higher concentration than other tissues this could be suggestive of a critical role in this 
tissue. The ability to determine tissue levels of selenoprotein W by an immunological 
assay as shown in the present report should assist in the determination of its role in 
normal muscle metabolism and possibly how it  is involved in the prevention of 
nutritionally induced myopathies. 
The reason we used peptides with the most hydrophilic character is because work 
by others indicated that the hydrophilic peptides are the most antigenic (40). The first 
region of the protein contains two prolines, which are very antigenic. We have also made 
polyclonal antibodies to the second hydrophilic region (amino acids 51-64), which we 
have called peptide 2.  In addition, monoclonal antibodies have been made to both 
peptides. Unfortunately, neither of the two monoclonal antibodies would function in the 
Western blots with tissue cytosols. 57 
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ABSTRACT 
Two experiments were conducted to evaluate the influence of dietary selenium on 
tissue levels of selenoprotein W. Glutathione peroxidase (GPX) activity and selenium 
levels were also determined for comparative measurements. In the first experiment rats 
were fed a basal deficient diet or this diet supplemented with either 0.1 or 4.0 mg 
selenium per kg diet. Selenoprotein W levels were significantly higher in muscle, brain, 
spleen and testes of rats fed the diet with 0.1 mg selenium per kg as compared to 
controls, but those fed the diet with 4.0 mg selenium per kg had even higher levels than 
those fed the diet with 0.1 mg selenium per kg. There was a corresponding increase of 
mRNA encoding selenoprotein W with each increase of dietary selenium. In the second 
experiment rats were fed the basal diet or this plus 0.03, 0.05, 0.1, 0.5, 1.0, 2.0 or 4.0 
mg selenium per kg diet. The levels of selenoprotein W in muscle started to increase 
with 0.06 mg selenium per kg and then increased markedly with 1.0 mg selenium per kg 
diet where a plateau was reached. There was a linear increase of selenoprotein W in brain 
and spleen with the selenium content in the diet, except a plateau was reached at 1.0 mg 
selenium per kg diet in the spleen. The testes showed a different pattern in that a very 
marked increase, as compared to controls, occurred with 0.01 mg selenium per kg diet 
where a plateau was reached. Except for the muscle, GPX activities reached a plateau 
in all tissues from 0.06 to 0.1 mg selenium per kg diet. The selenium content in these 
tissues increased at a linear rate with the selenium content in the diets.  The results 
indicate that the regulation of selenoprotein W by selenium is different in various tissues 
and also differs from that for GPX. 63 
INTRODUCTION  
At present there are four known members of the family of glutathione peroxidases 
(GPX). The first to be recognized was the cellular GPX (cGPX, Rotruck et al, 1973). 
A GPX was purified from plasma (GPX-p) and shown to be immunochemically distinct 
from the cGPX (Takahashi et al, 1987). A third GPX was discovered to be capable of 
reducing fatty acid hydroperoxides esterified to phospholipids (Ursini et al, 1985) and has 
been identified as PHGPX.  Evidence was obtained for a fourth GPX found 
predominantly in the gastrointestinal tract (Chu et al, 1993) and is designated as GPX-GI. 
The use of graded levels of dietary selenium allows investigators to determine the 
selenium response curves for various parameters. PHGPX and cGPX have been shown 
to be differentially regulated by selenium status (Lei et al, 1995). Liver cGPX activity 
was highly regulated by selenium status with virtually no activity in rats fed a selenium 
deficient diet. Relative plateau levels of activity was reached with 0.1 mg selenium per 
kg diet (Hafeman et al, 1974; Knight and Sunde, 1987). In contrast, liver PHGPX was 
reduced only 40% of plateau with the deficient diet but reached relative plateau levels 
with dietary selenium levels less than 0.1 mg selenium per kg (Lei et al,  1995). 
Therefore, since the two GPXs are differentially regulated, other selenoproteins are likely 
to be affected differently by selenium. 
A low molecular weight selenoprotein, selenoprotein W, was recently purified and 
characterized (Vendeland et al, 1993). In rats fed a regular diet, Western blots indicated 
that this selenoprotein is detectable in muscle, brain, spleen and testes (Yeh et al, 1995). 
This selenoprotein was found to be undetectable in muscle of deficient rats but was 64 
present in this tissue of rats given selenium, suggesting that selenium status will affect the 
level of this selenoprotein. This is supported by information showing that mRNA levels 
for selenoprotein W are affected by selenium status (Vendeland et al, 1995). However, 
no information is available on the regulation of this selenoprotein by selenium and this 
is the purpose of this study. The response of this selenoprotein with respect to selenium 
status was investigated and is reported in this communication. 65 
MATERIALS AND METHODS  
Animal Treatment 
Two experiments were conducted to evaluate the influence of selenium on 
selenoprotein W levels in tissues.  In the first experiment, male weanling rats (4 weeks 
of age) were fed either the deficient diet (no selenium added) or this diet supplemented 
with either 0.1 or 4.0 ppm selenium for 6 weeks. In the second experiment, the rats were 
fed the deficient diet or this diet supplemented with either 0.01, 0.03, 0.06, 0.1, 1.0, 2.0 
and 4.0 ppm selenium for 8 weeks. Selenium was added in the form of sodium selenite. 
The basal diet was composed of 30% torula yeast (Rhinelander paper Co, Rhinelander, 
Wis.), 51% sucrose, 9% purified cellulose (Solka Floc, Brown Co., Berlin, NH) 5% corn 
oil, 3.5% AIN-93M mineral mix without selenium and 1% AIN-76 vitamin mix 
(American Institute of Nutrition, 1977), 0.3% L-methionine and 0.2 % choline citrate. The 
basal diet in both experiments was shown by analysis to contain about 0.03 mg selenium 
per kg diet. In both studies, the animals were anesthetized with sodium pentobarbital (80 
mg/kg i.p) and blood was taken via cardiac puncture. After the rats were decapitated 
while under anesthesia, the tissues were removed and frozen immediately afterward at 
70°C. The tissues were kept frozen at this temperature until used. Selenoprotein W levels 
and GPX activities were measured on all tissues examined. 66 
Western Blot Analysis 
Tissues were homogenized in 6 volumes of buffer A (20 mM Tris [pH 7.5], 0.25 
M sucrose, 1 mM EGTA, 5 mM EDTA, 1 mM PMSF, 50 mM B-mercaptoethanol and 
25 ug/ml leupeptin), and were centrifuged at 17,000 xg for 10 min at 4°C. Protein content 
was measured in the supernatants by the dye-binding assay of Bradford (1976) using 
bovine serum albumin (Bio-Rad, Richmond, CA) as standards. Samples (200 jig protein 
each) were electrophoretically separated on SDS-polyacrylamide 7.5 to 15% gradient gels 
as described by Laemmli (1970). Proteins were transferred onto nitrocellulose membranes 
(0.2 iim, BA-S83; Schleicher & Schuell, Keene, NH) in transfer buffer (25 mM Tris, 192 
mM glycine and 20% methanol) at 4°C according to method of Towbin et al. (1979). 
After transfer, membranes were incubated with blocking solution (5% non-fat dried milk 
in TTBS [0.05 % Tween 20 in TBS]) at 25°C for 1 hr, then incubated with rabbit anti-
selenoprotein W polyclonal antibody at 25°C for 1.5 hr. Following three washes, 
membranes were incubated with horse-radish peroxidase-conjugated goat anti-rabbit IgG 
antibody (Bio-Rad, Richmond, CA). Membranes were then washed four times with TTBS 
and specific bonding of anti-selenoprotein W antibody onto membrane was detected by 
ECL detection system (Amersham, Arlington, IL). The membrane was then exposed to 
Kodak X-OMAT film (Eastman Kodak Co., Rochester, NY). Developed films were 
scanned with a Personal Densitometer SI (Molecular Dynamics, Sunnyvale, CA) analyzed 
by the ImageQuaNT program (Molecular Dynamics, Sunnyvale, CA). 67 
Total RNA Extraction 
Extraction of total RNA has been described previously (Chomczynski and Sacchi, 
1987).  Briefly, tissue was homogenized in 2 ml of solution A (4 M guanidium 
isothionate,  25 mM sodium citrate [pH 7.0], 0.5% sarcosyl and  10 mM B-
mercaptoethanol) and then transferred to a 15 ml polypropylene tube. To this, 0.2 ml of 
2 M sodium acetate (pH 4.0), 2 ml of phenol and 0.4 ml of a chloroform-isoamyl alcohol 
mixture (49:1) were added sequentially and mixed by inversion after each addition. After 
brief vortexing, the mixture was kept on ice for 15 min and was separated by 
centrifugation (12,000 g) for 30 min at 4°C. The upper aqueous phase was transferred 
to a new tube and then an equal volume of ice-cold isopropanol was added. The samples 
were mixed and stored at -20°C overnight. RNA was collected by centrifugation (12,000 
g, 20 min at 4°C). The supernatant was discarded and the RNA pellet was resuspended 
in 0.4 ml of solution A. One volume of isopropanol was added, and the mixture was 
stored at -20°C overnight. The RNA pellet was recovered by centrifugation at 12,000 g 
for 15 min at 4°C, washed twice with 70% ethanol and dried under a vacuum. The dried 
RNA pellet was then dissolved in diethylpyrocarbonate (DEPC)-treated water and was 
quantitated by spectrophotometry at a wavelength of 260 nm. 
Northern Blot Analysis 
Total RNA samples (25 lig) were denatured at 55°C for 15 min, applied to a 1.2% 
agarose gel containing 2.2 M formaldehyde, then electrophoresed at 30 V for 12 h. RNA 68 
was transferred onto nylon membranes (GeneScreenPlus, DuPont/NEN) and immobilized 
by baking at 70°C for 40 min. Selenoprotein W cDNA and 16 S ribosomal RNA 
oligonucleotides (Giovannoni, 1991) were labeled by using DIG Labeling Kit (Boehringer 
Mannheim Biochemica, Indianapolis, IN). The RNA membrane was hybridized and 
washed according to the procedures described in DIG Luminescent Detection Kit for 
Nucleic Acids (Boehringer Mannheim Biochemica, Indianapolis, IN). Briefly, membranes 
were prehybridized at 42°C for 1 hr in hybridization buffer (50% formamide, 5 X SSC, 
0.02%  SDS,  0.1  %  N-lauroylsarcosine  and 2%  Blocking  Reagent).  After 
prehybridization, heat-denatured DIG labeled selenoprotein W probe was added to 
hybridization buffer and membrane was hybridized at 42°C overnight. Next day, the 
membrane was washed in 0.5 X SSC with 0.1% SDS at room temperature. After washing 
briefly in Buffer 1 containing 0.3% Tween 20, the membrane was incubated in Buffer 2 
for 30 min. Anti-digoxigenin-AP conjugated antibody was diluted in Buffer 2 (1:5000) 
and the membrane was incubated in this buffer for 30 min. The unbound antibody 
conjugate was removed by washing the membrane in Buffer 1. The membrane was then 
equilibrated in Buffer 3 for 2 min and substrate solution was added. After incubation at 
37°C for 5 min, the excess substrate was removed and the membrane was exposed to 
Kodak X-OMAT film (Eastman Kodak Co., Rochester, NY). Developed films were 
scanned with a Personal Densitometer SI (Molecular Dynamics, Sunnyvale, CA) and 
analyzed by the ImageQuaNT program (Molecular Dynamics, Sunnyvale, CA). Before 
hybridization to the internal control probe, the membrane was rinsed thoroughly in water 
and then incubated in stripping buffer (50% formamide, 50 mM Tris-HC1 [pH 8.0], and 
1% SDS) at 68°C for 1 hr to remove the probe. After rinsing with water and in 2 X SSC, 69 
the membranes were used for hybridization of internal control probe (16 S rRNA 
oligonucleotides). 
Glutathione Peroxidase Activity and Selenium Content 
cGPX activity was measured by an enzyme coupled method using glutathione 
reductase, utilizing hydrogen peroxide (0.171 mM) as substrate (Pagli and Valentine, 
1967) by a DU Series 60 Spectrophotometer (Beckman Instrument, Fullerton, CA). After 
digestion of the tissue fractions with nitric and perchloric acids, selenium was determined 
by the semiautomated fluorimetric method (Brown and Watkinson, 1977) using an 
Alpchem II system (Alpchem. Corp., Milwaukie, OR). 
Statistical Analysis 
Data were examined for equal variance and normal distribution prior to statistical 
analysis. Mean values were compared by analysis of variance (ANOVA) with Fisher's 
least-significant difference (LSD) method for comparing groups (Steel and Torrie, 1980). 
A significance level of 5% was adopted for all comparisons. 70 
RESULTS  
Experiment 1. 
There were no differences in the food consumption of the rats in this study. 
However, the rats fed the deficient diet gained (181 ± 5 gms) significantly less (P < 0.05) 
than those fed the other two diets (197 ± 5 for those fed 0.1 mg selenium per kg diet or 
211 ± 4 for those fed 4.0 mg selenium per kg diet). There were no differences in the 
weight gains between rats fed the 0.1 mg selenium per kg diet versus those fed the 4.0 
mg selenium per kg diet. 
Except for the brain, there was a corresponding increase of tissue selenium with 
each increase of dietary selenium (Table 3-1). There was not a statistical increase of the 
selenium content of the brain. Except for the testis, the selenium content was higher in 
tissues from rats fed the 0.1 mg selenium per kg diet than those fed the basal diet, and 
those fed the 4.0 mg selenium per kg diet were higher than in tissues from those fed the 
0.1 mg selenium per kg diet. The selenium content in the testes from rats fed the 0.1 mg 
selenium per kg diet was higher than in this organ from rats fed the basal diet but this 
content in testes was not significantly higher in rats fed the 4.0 mg selenium per kg diet 
as compared to those fed the 0.1 mg selenium per kg diet. 
The cGPX and GPX-p activities were significantly higher as compared to the 
respective lower level of selenium fed in plasma, testes and spleen (Table 3-2). 
However, even though this activity was higher in muscle in rats fed the 0.1 mg selenium 
per kg diet than muscle from control rats, there was not further significant increases when 71 
Table 3-1. Tissue selenium content of rats fed Torula yeast diets supplemented with 0, 
0.1 or 4.0 mg selenium as selenite per kg. 
Tissues  0 ppm Se  0.1 ppm Se  4.0 ppm Se 
plasma  0.03±0.001a  0.38±0.02b  0.45±0.02c 
muscle  0.14±0.01a  0.41±0.016  0.71±0.10a 
brain  0.52±0.02  0.56±0.09  0.71±0.06 
testis  5.08±0.1P  6.92±0.45"  7.75±0.18" 
spleen  0.63±0.03'  1.70±0.04"  3.02±0.26` 
liver  0.07±0.02a  1.67±0.04"  3.15±0.28` 
* Values are means of each treatments ± SE. Different superscripts denote significance 
(p < 0.05). 
** Tissue selenium contents are expressed as 1.1g Se/ g dry weight. 72 
Table 3-2. GPX activities of rats fed Torula yeast diets supplemented with 0, 0.1 or 4 mg 
selenium as selenite per kg. 
Tissues  0 ppm Se  0.1 ppm Se  4.0 ppm Se 
plasma  3.4±0.2'  47.9±2.5"  58.8±1.7c 
Muscle  36.7±2.4a  146.9±13.4"  179.4±21.8" 
Brain  83.4±2.6'  82.2±1.9a  103.4±6.0" 
Testis  55.6±1.6'  103.3±1.0"  118.2±4.3` 
Spleen  249.5±17.7a  594.1±14.0"  685.8±4.4` 
* Values are means of each treatments ± SE. Different superscripts denote significance 
(p < 0.05). 
** GPX activity expressed as nmoles NADPH oxidized/min/mg protein. 73  
4.0 mg selenium  was present  in the diet. The brain showed a different pattern 
in that this activity was not significantly higher in rats fed the 0.1 mg selenium diet versus 
those fed the basal diet, but was significantly higher in this tissue of rats fed the 4.0 mg 
selenium per kg diet. 
Western blots for selenoprotein W in brain, testes and spleen are shown in figure 
3-1  These blots for the muscle are shown in an earlier publication (Yeh et al, 1995). 
The density of the bands were used to determine the concentration of selenoprotein W in 
tissues. 
Selenoprotein W was not detectable in muscle of deficient rats, but was present 
in muscle of rats fed the diet with 0.1 mg selenium per kg (Table 3-3).  Those fed 4.0 
mg selenium per kg had significantly higher (P < 0.05) levels in the muscle than in 
muscle from those fed the 0.1 mg selenium per kg diet. 
Northern blots of tissues are shown in figure 3-2.  The intensities of the bands 
were greatest for testes, muscle and brain. This information was used to calculate the 
relative levels of mRNA in tissues. 
The northern blots of the muscle from rats fed the three levels of selenium are 
shown in figure  3-3.  The intensities of the bands increased with each increase of the 
dietary selenium levels. 
The information in the Northern blots was used to determine the relative mRNA 
levels in rats fed the three levels of dietary selenium (Table 3-4). The mRNA levels when 
expressed as the ratio to the internal standard increased significantly (P < 0.05) with each 
increase of dietary selenium. 74 
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Figure 3-1. Western blots of selenoprotein W in different tissues of rats fed Torula yeast 
diets with various selenium supplementation. (A) Brain, (B) Testis and (C) Spleen. Lanes 
1-6 are from rats fed basal diet. Lanes 7-11 are from rats fed 0.1 ppm Se diet. Lanes 12-
15 are from rats fed 4.0 ppm Se diet. 75 
Table 3-3. Effects of selenium status on selenoprotein W of rats fed Torula yeast diets 
supplemented with 0, 0.1 or 4 mg selenium as selenite per kg. 
Tissue  0 ppm Se  0.1 ppm Se  4.0 ppm Se 
Muscle  N.D.  893±181'  2235±383b 
Brain  722±59'  728±67'  1066±182" 
Testis  359±6'  638±56b  613±31" 
Spleen  242±34'  599±40b  829±45c 
* Values are means of each treatments ± SE. Different superscripts denote significantly 
different (p < 0.05). The values are given in scan units. 
** N.D. = non-detectable. 76 
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Figure 3-2. Tissue distribution of selenoprotein W mRNA from rat fed 4 ppm Se diet. 
(A) Hybridization to selenoprotein W cDNA probe (B) Hybridization to internal control 
probe (18 S rRNA). T: testis, Lu: lung, M: muscle, Sp: spleen, Li: liver, K: kidney, I: 
intestine, B: brain and H: heart. 77 
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Figure 3-3. Northern blots of selenoprotein W mRNA in muscles from rats fed Torula 
yeast diets with additions of 0, 0.1 and 4.0 ppm Se. (A) Hybridization to selenoprotein 
W cDNA probe (B) Hybridization to internal control probe (18 S rRNA). Lanes 1-6 are 
from rats fed basal diet. Lanes 7-11 are from rats fed 0.1 ppm Se diet. Lanes 12-15 are 
from rats fed 4.0 ppm Se diet. 78 
Table 3-4. Northern blot data of selenoprotein W (Se-W) mRNA and internal control (18 
S rRNA) mRNA in muscles of rats fed Torula yeast diets supplemented with 0, 0.1 and 
4 mg selenium as selenite per kg. 
mRNA  0 ppm Se  0.1 ppm Se  4.0 ppm Se 
Se-W  1287±289k  4982±226b  5891±4516 
18 S rRNA  4638±442  3798±411  3493±415 
Ratio  0.3±0.1a  1.4±0.16  1.7±0.2c 
* Values are means of each treatments ± SE. Different superscripts denote significantly 
different (p < 0.05). 
** Data are expressed as scan units. Ratio = Se-W/ 18 S rRNA. 79 
Experiment 2. 
The weight gain and feed consumption of the rats in this experiment are shown 
in Table  3-5.  There were no differences in feed consumption between the different 
dietary groups. However, there were some differences in weight gain. Those fed the 
diet with 0.03 mg selenium per kg gained significantly (P <  0.05) more than those fed 
the diets with the two lower levels of this element. The weight gain of those rats fed the 
diet with 4 mg selenium per kg were not significantly different from controls or those fed 
the diet with 0.01 mg selenium per kg. 
The whole blood and hepatic selenium levels were determined as a measure of the 
selenium status of the animals (figure 3-4).  A nearly linear increase of selenium content 
occurred in both whole blood and liver with increased levels of this element in the diet. 
Western blots of selenoprotein W in muscles from rats fed various dietary 
selenium was shown in figure 3-5. The selenium content, GPX activity and selenoprotein 
W levels in muscle followed different patterns with respect to selenium intake (figure 3-
6). Increase of selenium levels occurred with increased dietary selenium intake. GPX 
activity also increased with increased selenium intake but reached a plateau at 2.0 mg 
selenium per kg diet. The first detectable level of selenoprotein W was in muscle from 
rats fed the diet with 0.06 mg selenium per kg. A very marked increase of selenoprotein 
W occurred with the two next highest levels of selenium where a plateau was reached at 
1.0 mg selenium per kg diet. 80 
In contrast to the muscle, similar patterns of increase occurred for cGPX activity, 
and selenium and selenoprotein W contents in brain with respect to the selenium content 
in the diet (figure 3-7). 
The pattern of selenoprotein W in the testes was different from that seen in the 
other tissues (figure 3-8). The selenoprotein W content increased significantly (P < 0.05) 
in rats fed the diet with 0.01 mg selenium per kg as compared to the controls. There 
were only slight increases of this selenoprotein with higher levels of selenium. This is 
in contrast to the selenium content and cGPX activity where plateaus were reached at 
about 0.06 mg selenium per kg diet. 
A fairly linear increase of selenoprotein W occurred in the spleen with the 
increase of dietary selenium to 1.0 mg per kg, where a plateau was reached (figure 3-9). 
The cGPX activity reached a plateau at 0.06 mg selenium per kg diet but the selenium 
content continued to increase with increases of dietary selenium. 81 
Table 3-5. Average food intake and total weight gain for rats fed Torula yeast diets 
supplemented with 0, 0.01, 0.03, 0.06, 0.1, 1, 2 or 4 mg selenium as selenite per kg 
diet. 
Diet  Weight gain  Food intake 
(mg Se kg) 
0  196±3a  14.9±0.2 
0.01  203±71°  15.4±0.3 
0.03  231±5C  16.6±0.5 
0.06  207±40  15.9±0.3 
0.1  220±7b'c  15.9±0.6 
1  216±4b'c  16.2±0.2 
2  211±10a'b  15.5±0.2 
4  196±7a  16.0±0.3 
* Values are means of each treatments ± SE. Different superscripts denote significantly 
different (p < 0.05). 
** Weight gain is given as grams per rat for the entire study. Food consumed is given 
as grams per rat per day. 82 
1 000  6000 
800   4800  
600   3600  
400   2400  
200   1200  
0  0 
0	  0.01 0.03 0.06  0.1  1  2  4  
Rat diets (mg Se/ kg)  
Figure 3-4. Selenium content of whole blood and liver tissue from rats fed various levels 
of dietary selenium. The whole blood selenium are expressed as ng/ml and the selenium 
for liver are expressed as ng/ g dry weight. 83 
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Figure 3-5. Western blot analysis of selenoprotein W in muscles from rats fed various 
levels of dietary selenium. Lanes A1-5 are from rats fed basal diet. Lanes B1-5 are from 
rats fed 0.01 ppm Se diet. Lanes C1-5 are from rats fed 0.03 ppm Se diet. Lanes D1-5 
are from rats fed 0.06 ppm Se diet. Lanes E1-5 are from rats fed 0.1 ppm Se diet. Lanes 
F1-5 are from rats fed 1.0 ppm Se diet. Lanes G1-5 are from rats fed 2.0 ppm Se diet. 
Lanes H1-5 are from rats fed 4.0 ppm Se diets. 84 
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Figure 3-6. Selenoprotein W level (scan unit), GPX activity (nmol NADPH oxidized/ 
min/ mg protein) and tissue selenium content (ng/ g dry weight) in muscle from rats fed 
various levels of dietary selenium. 85 
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Figure 3-7. Selenoprotein W level (scan unit), GPX activity (nmol NADPH oxidized/ 
min/ mg protein) and tissue selenium content (ng/ g dry weight) in brain from rats fed 
various levels of dietary selenium. 86 
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Figure 3-8. Selenoprotein W level (scan unit), GPX activity (nmol NADPH oxidized/ 
min/ mg protein) and tissue selenium content (ng/ g dry weight) in testis from rats fed 
various levels of dietary selenium. 87 
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Figure 3-9. Selenoprotein W level (scan unit), GPX activity (nmol NADPH oxidized/ 
min/ mg protein) and tissue selenium content (ng/ g dry weight) in spleen from rats fed 
various levels of dietary selenium. 88 
DISCUSSION  
Various levels of dietary selenium indicated that this element affects selenoprotein 
W differently in the tissues studied. The results of the first experiment indicated that 
selenoprotein W responded to selenium intake, but those of the second experiment gave 
more precise information on the regulation of selenoprotein W by selenium. It is obvious 
that the regulation of selenoprotein W by selenium is different between tissues and also 
differs from that for cGPX. A very marked increase of selenoprotein W was found in 
muscle when levels of selenium greater than 0.06 mg selenium per kg were fed to the rats 
(figure 3-5 and 3-6).  This is in contrast to the testes where a plateau was reached with 
only 0.01 mg selenium per kg diet (figure 3-8).  Presumably this means that the selenium 
responsive turnover elements are more sensitive in the testes than the muscle. The 
patterns in the brain (figure  3-7) and spleen (figure  3-9) were more linear with the 
selenium intake. However, a plateau was reached in the spleen at 1.0 mg selenium per 
kg, which is similar to that found in the muscle. 
The regulation of cGPX by selenium is different from selenoprotein W. The 
plateau for cGPX was reached at 0.1 mg selenium per kg diet in the brain (figure 3-7), 
at 0.06 mg selenium per kg diet in both the testes (figure  3-8) and spleen (figure 3-9) but 
this plateau in muscle was not reached until 1.0 mg selenium per kg diet was fed (figure 
3-5 and  3-6).  As far as we know these results with the muscle have not been reported 
previously. The regulation of cGPX and PHGPX activities were studied in liver, heart, 
kidney, lung and testes with rats (Lei et al,  1995).  Plateaus in activities for both 
isoenzymes of GPX was reached from  75 to 130 micrograms selenium per kg diet. 89 
Except for the muscle, the present results with the various tissues are consistent with 
those obtained by other investigators who indicated this plateau is reached around 0.1 mg 
selenium per kg diet (Hafeman et al, 1974; Knight and Sunde, 1987). 
The rapid response of selenoprotein W to selenium in the testes is similar to that 
reported for PHGPX. The levels of selenoprotein W reached a plateau at only 0.01 mg 
selenium per kg (figure 3-8) whereas the plateau for PHGPX was reported to be reached 
at 0.025 mg selenium in the testes (Lei et al, 1995). This may suggest that these two 
selenoproteins have similar response elements in testes. 
The question arises as to the regulation of selenoprotein W by selenium. Table 
3-4 indicates that the mRNA levels for selenoproteins are sensitive to selenium. 
However, additional information is needed to evaluate this regulation.  In other work, 
nuclear run-off transcription assays show that selenium status has no effect on the 
transcription of cGPX mRNA levels (Christensen and Burgener, 1992, Toyoda et al, 
1990), suggesting that selenium status influences the stability of cGPX mRNA. 
Experiments are presently planned to evaluate the mechanism of regulation of 
selenoprotein W by selenium as to whether this is through transcription or through 
stability of mRNAs. The reason for different responses between cGPX and selenoprotein 
W in various tissues are not known. One hypothesis could be that there exist rapid 
turnover elements in cGPX that are not present in selenoprotein W mRNA. Reduced 
selenium status would elicit degradation of cGPX mRNA but not in selenoprotein W 
mRNA or mRNA for other selenoenzymes.  An alternative hypothesis is  that 
selenocysteine insertion sequences in the mRNA which are necessary for selenium 
insertion (Berry et al, 1993) may also affect stability. Berry et al (1993) found different 90 
levels of deiodinase activity in cells transfected with recombinant deiodinase fusion genes, 
depending on which selenoprotein provided the selenocysteine insertion sequence. 
Prior work indicated that selenoprotein W was present in the muscle, brain, testes 
and spleen of rats (Yeh et al, 1995). However, there are some species differences in the 
tissue distribution of this selenoprotein.  When selenium is given to sheep, the 
selenoprotein W content is just as high in the heart as in the muscle (Yeh et al, 1996). 
Although selenoprotein W was not detectable in hearts from rats, there is mRNA present 
in this organ (unpublished data), suggesting that mRNA levels are not correlated with 
selenoprotein W content in all tissues.  Experiments on the influence of selenium on 
transcription and on stability should help to unravel these unknown aspects. 
There is some information to suggest different affinities of various tissues for 
selenoprotein W. When sheep were fed a selenium deficient diet for about three months, 
selenoprotein W was significantly lower in all tissues examined except for the brain in 
comparison to selenium supplemented sheep (Yeh et al, 1996). However, the selenium 
content in the brain was 50% lower in the deficient sheep versus those getting selenium. 
This suggests preferential retention of selenoprotein W in the brain as compared to 
selenium. 
The metabolic function of selenoprotein W is not known. Selenoprotein P and 
mitochondrial capsule selenoprotein (MCS, Karimpour et al, 1992) are the other two most 
studied selenoproteins without a known function. Selenoprotein P is present in plasma 
of rats (Read et al, 1990) and humans (Deagen et al, 1993) and has been shown to 
contain 10 selenocysteines (Hill et al, 1991).  Like selenoprotein W, the levels of 
selenoprotein P are affected by the selenium status of the animal (Yang et al, 1989). 91 
MCS is the only other known selenoprotein which contains more than one selenocysteine 
per subunit (Karimpour et al, 1992). 
Selenium deficiency results in a muscular and cardiac degeneration, White Muscle 
Disease, in lambs and calves (Schubert et al, 1961).  Likewise, a severe nutritional 
selenium deficiency in discrete regions of China was associated with an endemic juvenile 
cardiomyopathy disorder called Keshan disease (Chen et al, 1980). Muscle weakness has 
been shown to be prevented by selenium supplementation in patients on long-term 
parenteral nutrition (Brown et al, 1986).  Therefore, there is sufficient evidence to 
indicate that selenium is important for normal muscle metabolism. Whether selenoprotein 
W has any significant role in muscle metabolism cannot be determined from the present 
work, but it is predicted that the higher level in the muscle is not a coincident. 92 
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ABS I RACT  
Rat L8 muscle cells were cultured to examine the effects of selenium and serum 
concentration on selenoprotein W levels and glutathione peroxidase (GPX) activities. The 
data from various differentiation stages of L8 muscle cells indicated that there is no 
significant difference (p < .05) in selenoprotein W levels and GPX activities during 
differentiation. Selenoprotein W levels and GPX activities increased in L8 myotubes 
cultured in media supplemented with 3 different forms of selenium. Selenite was utilized 
more efficiently than selenocysteine for both selenoprotein W and GPX activity. Selenium 
as selenomethionine appeared to be the least available form for L8 cell usage in the 
synthesis of selenoprotein W and GPX. However, cysteine and methionine did not affect 
the selenoprotein W levels and GPX activities in L8 myotubes. The selenium content of 
the media was shown to affect both the protein and mRNA levels for selenoprotein W. 
The selenoprotein W levels and GPX activities increased in L8 muscle cells incubated 
with selenium for 48 hr. Selenium concentrations of 10-6 M and 10-7 M gave similar 
responses of selenoprotein W content in cultured L8 myotubes. Northern blot data 
indicated that the expression of selenoprotein W mRNA increased significantly when L8 
myotubes were cultured with selenium (p < .05). These results imply that in addition to 
co-translational regulation, the regulation of selenoprotein W synthesis by selenium is, as 
least in part, at the transcriptional level. Selenoprotein W levels and GPX activities of L8 
myotubes were both lower (p < .05) in media with low serum concentration (2 %CS) 
than in media with high serum concentration (10 %CS). However, there is no significant 
difference in selenoprotein W levels and GPX activities of L8 myotubes cultured in 97 
10%CS versus 2%CS with addition of 10-8 M selenite (p > .05). These results suggest 
that the increase of selenoprotein W level in L8 myotubes cultured with higher serum 
concentration (10%CS) is due to the higher selenium concentration in media, rather than 
serum itself. 98 
INTRODUCTION  
Several selenoproteins have been found in mammalian tissues, but only two of 
these have known functions. There is a family of selenium-dependent glutathione 
peroxidases and to date there has been four members identified. The cellular glutathione 
peroxidase (cGPX) was the first one of this family discovered (1).  Subsequently, the 
plasma GPX (pGPX, ref 2), phospholipid hydroperoxidase GPX (PHGPX, ref. 3) and 
gastrointestinal tract specific GPX (GPX-GI, ref. 4) have been identified.  The other 
known mammalian selenoenzymes are type I  (5) and type III  (6) iodothyronine 
deiodinases.  The type I enzyme converts thyroxine to triiodothyronine and type III 
converts thyroxine to the inactive metabolite called reverse T3. 
There are three mammalian selenoproteins identified in which there is no known 
function. The most studied one is selenoprotein P.  It contains more selenium than any 
known protein. The cDNA for selenoprotein P has been cloned and sequenced (7) and 
contains 10 TGAs in the open reading frame. Thus it contains 10 selenocysteine residues 
in its primary structure. The only other selenoprotein known to possess more than one 
selenocysteine per subunit is mitochondrial capsule selenoprotein (MCS), which contains 
all three selenocysteines in the first 35 amino acids of a total of 197 residues (8). A third 
selenoprotein was recently characterized from our laboratory (9) and contains only 87 
amino acid residues (10). Evidence has been presented for a number of other selenium 
containing proteins, but none of these has been characterized (11). 
Cell cultures have been extremely useful in studying selenium metabolism. This 
was used to demonstrate that selenite was more effective than selenomethione (Semet) for 99 
increasing GPX activity (12, 13). The conversion of Semet to selenocysteine was shown 
to be influenced by the methionine content of the media (13).  Various selenium 
compounds have been studied in transsulfuration defective cells (14), and again higher 
levels of Semet were required to induce the same amount of GPX activity than either 
selenite or selenocysteine.  Recognition of UGA as a selenocysteine codon in type I 
iodothyronine deiodinase was demonstrated in vitro (15), further demonstrating the value 
of this technique. Hence, cell cultures were used in the present investigation to study the 
influences of selenium and serum on selenoprotein W levels. 
The L8 muscle cell line was originally established in 1969 by serial passage of 
myoblasts isolated from primary rat skeletal muscle cultures prepared from newborn 
Wistar rats (16). Of the tissues examined, selenoprotein W was highest in muscle from 
both rats (17) and sheep (18). Thus, experiments with rat muscle appears to be the most 
desirable tissue for studying the influences of selenium status and serum concentration on 
selenoprotein W levels. Therefore, rat L8 skeletal muscle cells were used in the present 
investigations. 100 
MATERIALS AND METHODS  
Materials 
L8 rat myoblast cells were obtained from American Type Culture Collection 
(Rockville, MD). Calf serum (CS) was purchased from Hyclone (Logan, UT). 
Dulbecco's modified Eagle's media (DMEM), penicillin/streptomycin solution and trypsin 
were purchased from GIBCO (Grand Island, NY). Rainbow molecular weight marker and 
the ECL Western blotting detection system were purchased from Amersham (Arlington 
Heights, IL). Horse-radish peroxidase (HRP) conjugated goat anti-rabbit IgG and bovine 
serum albumin (BSA) were purchased from Bio-Rad (Richmond, CA). Cell culture petri 
dishes were purchased from Corning (Corning, NY). Nitrocellulose membrane was 
purchased from Schleicher & Schuell (Keene, NH). GeneScreenPlus nylon membrane was 
purchased from DuPont/NEN. 
Cell Culture 
Undifferentiated L8 myoblasts were cultured in basal media (DMEM, 100 units 
penicillin/ml,  100  lig  streptomycin/ml  and  44  mM sodium 
bicarbonate,  pH  7.4)  supplemented  with  10 %  CS  in  a 
humidified atmosphere of 5% CO2 and 95% air  at 37°C. The medium was 
changed every two days until cells reached confluence. Then medium was replaced with 
differentiation media (basal media with 2% CS) to induce differentiation. Microscopic 
examination was used to monitor cell differentiation. 101 
Cell Treatments 
Experiment 1. 
This experiment was conducted to evaluate the influences of differentiation and 
selenium on selenoprotein W levels. Basal media supplemented with 10% CS was used 
to culture and differentiate L8 muscle cells for 6 days. Cells were collected every 2 days 
during differentiation to examine the effect of differentiation on selenoprotein W. In 
addition, cells were cultured in basal media supplemented with 10% CS to reach 
confluence, then myoblasts were cultured in differentiation media with various selenium 
concentration (10' M, 10' M or 10' M Se as selenite) for 6 days to examine the long 
term effects of selenium on selenoprotein W. 
Experiment 2. 
Effects of different forms of selenium on selenoprotein W levels and GPX 
activities  were examined.  Four-day differentiated  myotubes were incubated  in 
differentiation media supplemented with various concentrations (10'M, 10-7M or 10-8M) 
of selenium as selenite, L-selenomethionine or L-selenocystine for 0, 16, 24 and 48 hr. 
L8 myotubes were also incubated in differentiation media supplemented with 10' M 
selenium as L-cysteine and L-methionine. 
Experiment 3. 
The effect of serum on selenoprotein W levels and GPX activities were 
investigated. Four-day differentiated myotubes were incubated with either basal media 102 
(without serum) or differentiation media. Each type of media were supplemented with 
various concentrations of selenium (10'M, 10'M and 10-8M) as selenite for 0, 16, 24 and 
48 hr. 
After treatments, each plate of cells were washed with ice-cold 1X PBS (pH 7.4) 
three times, then homogenate buffer (20 mM Tris [pH 7.5], 0.25 M sucrose, 1 mM 
EGTA, 5 mM EDTA, 1 mM PMSF, 50 mM B-mercaptoethanol and 25 ug/ml leupeptin) 
was added to each plate and cells were scraped into tubes. After sonicated for 10 seconds, 
the mixtures were centrifuged at 17,000 xg for 10 min at 4°C. Protein content was 
measured on the supernatants by the dye-binding assay of Bradford (19) using bovine 
serum albumin (Bio-Rad, Richmond, CA) as standards. Then these cell supernatants were 
used to measure selenoprotein W level by Western blotting technique and GPX activities 
by a coupled enzyme procedure. 
Selenium content was determined in the media before use to ensure the correct 
selenium concentration. 
Western Blot Assay 
This assay was conducted as described previously (17).  Briefly, the cell 
supernatants (150  lig  protein each) were electrophoretically separated on SDS-
polyacrylamide 7.5 to 15% gradient gels as described by Laemmli (20). Proteins were 
transferred onto a nitrocellulose membrane (0.2 gm; BA-S83, Schleicher & Schuell, 
Keene, NH) in transfer buffer (25 mM Tris, 192 mM glycine and 20% methanol) at 4°C 
according to method of Towbin et al. (21). After transfer, membranes were incubated 103 
with blocking solution (5% non-fat dried milk in TTBS [0.05% Tween 20 in TBS; pH 
7.5]) at 25°C for 1 hr, then incubated with rabbit anti-selenoprotein W polyclonal 
antibody at 25 °C for 1.5 hr. Following three washes, membranes were incubated with 
horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG antibody (Bio-Rad, 
Richmond, CA). Membranes were then washed four times with TTBS and specific 
bonding of anti-selenoprotein W antibody onto membrane was detected by ECL detection 
system (Amersham, Arlington, IL). The relative amounts of selenoprotein W present in 
the various samples were estimated by densitometric scanning of the X-ray film using a 
Personal Densitometer SI (Molecular Dynamics, Sunnyvale, CA) and analyzed by the 
ImageQuaNT program (Molecular Dynamics, Sunnyvale, CA). 
Glutathione Peroxidase Activity and Selenium Content 
GPX activity was measured by an enzyme coupled method with glutathione 
reductase utilizing hydroperoxide as substrate (22) by a DU Series 60 Spectrophotometer 
(Beckman Instruments, Fullerton, CA). After digestion of media with nitric acid and 
perchloric acid, the selenium content was determined fluorometrically by a semi-
automated method (23) using an Alpchem II system (Alpchem. Corp., Milwaukee, OR). 
Total RNA Extraction 
Extraction of total RNA has been described previously (24). Briefly, myotubes 
grown in 10-cm diameter dishes were washed three times with ice-cold phosphate 104 
buffered saline (PBS) and lysed directly on the dishes using 2 ml of solution A (4 M 
guanidium isothionate, 25 mM sodium citrate, pH 7.0, 0.5 % sarcosyl, and 10 mM B-
mercaptoethanol). The monolayer was scraped with a rubber policeman to ensure that 
all cells were released from the dishes. The lysate was transferred to a 15 ml 
polypropylene tube. To this, 0.2 ml of 2 M sodium acetate (pH 4.0), 2 ml of phenol and 
0.4 ml of a chloroform-isoamyl alcohol mixture (49:1) were added sequentially. The 
lysate was mixed by inversion after each addition. After brief vortexing, the mixture was 
kept on ice for 15 min and was separated by centrifugation (12,000 g) for 30 min at 4°C. 
The upper aqueous phase was transferred to a new tube and an equal volume of ice-cold 
isopropanol was added. The samples were mixed and stored at -20°C overnight. RNA 
was collected by centrifugation (12,000 g, 20 min at 4°C). The supernatant was discarded 
and the RNA pellet was resuspended in 0.4 ml of solution A. One volume of isopropanol 
was added, and the mixture was stored at -20°C overnight.  The RNA pellet was 
recovered by centrifugation at 12,000 g for 15 min at 4°C, washed twice with 70% 
ethanol and dried under a vacuum. The dried RNA pellet was then dissolved in 
diethylpyrocarbonate (DEPC)-treated water and was quantitated by spectrophotometry at 
a wavelength of 260 nm. 
Northern Blot Analysis 
Total RNA samples (25 lig) were denatured at 55°C for 15 min, applied to a 1.2% 
agarose gel containing 2.2 M formaldehyde, then electrophoresed at 30 V for 12 h. RNA 
was transferred onto nylon membranes (GeneScreenPlus, DuPont/NEN) and immobilized 105 
by baking at 70°C for 40 min. Selenoprotein W cDNA and 16 S ribosomal RNA 
oligonucleotides (33) were labeled by using DIG Labeling Kit (Boehringer Mannheim 
Biochemica, Indianapolis, IN). The RNA membrane was hybridized and washed 
according to the procedures described in DIG Luminescent Detection Kit for Nucleic 
Acids (Boehringer Mannheim Biochemica, Indianapolis, IN). Briefly, the membrane was 
prehybridized at 42 °C for 1 hr in hybridization buffer (50% formamide, 5 X SSC, 
0.02%  SDS,  0.1  %  N-lauroylsarcosine  and 2% Blocking  Reagent).  After 
prehybridization, heat-denatured DIG labeled selenoprotein W cDNA probe was added 
to hybridization buffer and membrane was hybridized at 42°C overnight. Next day, the 
membrane was washed in 0.5 X SSC with 0.1% SDS at room temperature. After washing 
briefly in Buffer 1 containing 0.3% Tween 20, the membrane was incubated in Buffer 2 
for 30 min. Then anti-digoxigenin-AP conjugated antibody was diluted in Buffer 2 
(1:5000) and the membrane was incubated in this buffer for 30 min. The unbound 
antibody conjugate was removed by washing the membrane in Buffer 1. The membrane 
was then equlibrated in Buffer 3 for 2 min and substrate solution was added. After 
incubation at 37°C for 5 min, the excess substrate was removed and the membrane was 
exposed to Kodak X-OMAT film (Eastman Kodak Co., Rochester, NY). Developed films 
were scanned with a Personal Densitometer SI (Molecular Dynamics, Sunnyvale, CA) and 
analyzed by the ImageQuaNT program (Molecular Dynamics, Sunnyvale, CA). Before 
hybridization to the internal control probe, the membrane was rinsed thoroughly in water 
and then incubated in stripping buffer (50% formamide, 50 mM Tris-HC1 [pH 8.0], and 
1% SDS) at 68°C for 1 hr to remove the probe. After rinsing with water and then in 2 106 
X SSC, the membrane was used for hybridization of internal control probe (16 S rRNA 
oligonucleotides). 
Statistical Analysis 
Data were examined for equal variance and normal distribution prior to statistical 
analysis. Mean values were compared by analysis of variance (ANOVA) with Fisher's 
least-significant difference (LSD) method for comparing groups (25). A significance level 
of 5% was adopted for all comparisons. 107 
RESULTS 
In the preliminary experiment, L8 muscle cells were cultured in basal media with 
10%CS to reach confluence and then serum concentration of media was reduced to 2% 
to induce the differentiation of myotubes. Some of the 4-day differentiated myotubes were 
incubated with either 10' M (Fig. 4-1, lane 14) or 10' M (Fig. 4-1, lane 13) selenium 
as selenite for 3 days. These data showed that selenoprotein W levels and GPX activities 
decreased gradually during differentiation (Fig. 4-1 and Table 4-1). When selenium was 
added to the media in the 4-day differentiated myotubes, the selenoprotein W levels and 
GPX activities increased after 3 day incubation in response to selenium supplementation 
(Fig. 4-1 and Table 4-1). 
Figure 4-2 showed the specific binding of antibody to selenoprotein W in L8 
muscle cells. The effect of differentiation on selenoprotein W levels and GPX activities 
is shown in Table 4-2. These results indicated that selenoprotein W levels remained 
unchanged during cell differentiation (p > .05). 
To further examine the long term effect of different selenium concentrations on 
selenoprotein W, L8 muscle cells which had differentiated in media were incubated with 
various concentrations of selenium as selenite for 6 days (Fig. 4-3). Both selenoprotein 
W level and GPX activity reached the plateau in media where 10' M Se as selenite was 
added (Table 4-3). These data showed that selenoprotein W increased as selenium 
concentration in media was increased (p < .05). 108 
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Figure 4-1. Western blot of selenoprotein W levels at various differentiation stages of rat 
L8 muscle cells. Lane 1-3: Pure selenoprotein W (15 ng, 10 ng, 5 ng). Lane 4 is 
myoblast in basal media + 10% CS. Lane 5-11 are 1-day, 2-day, 3-day, 4-day, 5-day, 
6-day and 7-day differentiated myotubes in basal media + 2% HS, respectively. Lane 12-
14 are 4-day differentiated myotubes incubated with different media (basal media + 2% 
HS, basal media + 2% HS +10-7M selenite, basal media + 2% HS + 10-6M selenite, 
respectively) for 3 days. 109 
Table 4-1. Selenoprotein W (Se-W) levels and GPX activities in various differentiation 
stages of L8 muscle cells, as shown in Fig. 4-1. 
Lane #  Se-W level 
4  91.6 
5  69.5 
6  47.8 
7  29.6 
8  4.7 
9  4.3 
10  N.D. 
11  N.D. 
12  N.D. 
13  N.D. 
14  6.8 
* ND = non-detectable 
GPX activity 
95.0 
105.8 
89.9 
72.8 
54.2 
43.3 
38.4 
32.2 
41.5 
64.2 
60.3 
** Selenoprotein level is expressed as ng/mg protein whereas GPX activity is expressed 
as nmol NADPH oxidized/min/mg protein. 110 
Figure 4-2. Western blot of selenoprotein W in L8 muscle cells. Rabbit polyclonal 
antibody against rat selenoprotein W peptide sequence was used in Western blot analysis. 
Lane 1 is pure selenoprotein W (5 ng) from rat muscle. Lanes 2 and 4 are L8 myoblast. 
Lanes 3 and 5 are 1-day differentiated muscle cells. For Western blot assay, lanes 2 and 
3 were incubated with primary antibody whereas lanes 4 and 5 were incubated with 
antibody which was preabsorbed (10 ug peptide/ ml antibody solution) with synthetic 
peptide of selenoprotein W. 111 
Table 4-2. Effect of differentiation on selenoprotein W level and GPX activity in L8 
muscle cells. 
Differentiated stage  Se-W level  GPX activity 
Day 0  69±20  81.9±3. P 
Day 2  120±20  104.3±1.9b 
Day 4  82±16  84.5±1.5a'c 
Day 6  111±18  90.4±2.3c 
* Values are expressed as mean ± S.E. Day 0 = beginning of differentiation. Day 6  = 
6 day differentiation. Different superscripts denote significant difference  (p < .05). 
Selenoprotein W level is expressed as scan unit whereas GPX activity is expressed  as 
nmol NADPH oxidized/min/mg protein. 
** L8 muscle cells were cultured and differentiated in basal media with 10%CS. 112 
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Figure 4-3. Western blot of selenoprotein W L8 myotubes cultured in differentiation 
media supplemented with various selenium concentration as selenite for 6 days. Rat L8 
myoblasts were grown to reach confluence in basal media + 10% CS, different media 
were used to differentiate myoblasts to myotubes. Lanes A1-5: differentiation  media 
(basal media + 2%CS). Lanes B1-5: differentiation media + 10-8M Se. Lanes C1-5: 
differentiation media + 10-7M Se. Lanes D1-5: differentiation media +  M Se. 113 
Table 4-3. Effect of various selenium concentrations on selenoprotein W level and GPX 
activity in 6-day differentiated myotubes, as shown in figure 4-3. 
Media  Se-W level  GPX activity 
Differentiation media (DM)  20±5*  83.3±7.8' 
DM + 10-8M Se  151±27b  109.9±5.3b 
DM + 10-7M Se  714±109c  149.4±7.3` 
DM + 10-6M Se  411±94d  143.7±8.8c 
* Values are expressed as mean ± S.E. Different superscripts denote significant difference 
(p < .05). Selenoprotein W level is expressed as scan unit whereas GPX activity is 
expressed as nmol NADPH oxidized/min/mg protein. 
** L8 muscle cells were cultured in basal media with 10% CS to reach confluence, then 
incubated in various media to differentiate for 6 days. 
*** Differentiation media = basal media + 2%CS. 114 
Figure 4-4 gives the GPX activities of rat L8 muscle cell incubated with 
differentiation media (basal media with 2% CS) with additions of 10-6 M, 10-7M or 10-8 
M selenium (Fig. 4-4A, 4-4B and 4-4C, respectively) as either selenite, selenocystine 
(SeCys) or selenomethionine (Se Met) for 16, 24 and 48 hr. Similar patterns were noted 
when the myotubes were incubated with either 10-6 M (Fig. 4-4A) or 10-7 M (Fig. 4-4B) 
selenium as these three sources. A greater lag in GPX activity was observed when 
myotubes were cultured with 10-8 M selenium as the three sources (Fig. 4C). GPX 
activity at 16 hr incubation did not differ from the initial values (p > .05). However, 
GPX activity increased to the greatest extent at 48 hr incubation with selenite (p < .05), 
followed by selenocysteine and selenomethionine. These results indicated that the 
availability of different selenium forms for GPX synthesis  is sodium selenite 
selenocystine > selenomethionine (p < .05). 
Effects of serum and selenium concentrations on GPX activity at various times are 
shown in Fig. 4-5. The patterns of GPX activities in myotubes in response to selenium 
concentrations for 10-6 M (Fig. 4-5A), 10-7 M (Fig. 4-5B) and 10.8 M (Fig. 4-5C) were 
similar. L8 myotubes cultured with basal media remained constant, but there were 
increases, although erratic, when serum was added to basal media (p < .05). When 
selenium was added to the incubation media, GPX activity increased dramatically to the 
greatest extent at 48 hr of incubation. There were no significant difference in GPX 
activities between myotubes incubated in basal media with serum and differentiation media 
with selenium (p > .05). 
Figure 4-6 shows the effects of different forms of selenium at 10-6 M on 
selenoprotein W level  during various incubation times. There were no significant 115 
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Figure 4-4A. Effects of different forms of Se on GPX activities (nmol NADPH 
oxidized/min/mg protein) in 4-day differentiated L8 myotubes cultured for various times 
(16, 24 or 48 hr). Culture media is differentiation media (basal media + 2% CS) with 
10-6M Se as selenite, L-selenomethionine or L-selenocystine. 116 
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Figure 4-4B. Effects of different forms of Se on GPX activities (nmol NADPH 
oxidized/min/mg protein) in 4-day differentiated L8 myotubes cultured for various times 
(16, 24 or 48 hr). Culture media is differentiation media with 10-7M Se as selenite, L-
selenomethionine or L-selenocystine. 117 
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Figure 4-4C. Effects of different forms of Se on GPX activities (nmol NADPH 
oxidized/min/mg protein) in 4-day differentiated L8 myotubes cultured for various times 
(16, 24 or 48 hr). Culture media is differentiation media with 10-8M Se as selenite, L-
selenomethionine or L-selenocystine. 118 
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Figure 4-5A. Effects of serum and selenium concentrations on GPX activities (nmol 
NADPH oxidized/min/mg protein) in 4-day differentiated L8 myotubes cultured for 
various times (16, 24 or 48 hr). Culture media is basal media (without serum), basal 
media with  10-6 M selenite,  differentiation media (basal media + 2%CS), or 
differentiation media with 10-6M selenite. 119 
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Figure 4-5B. Effects of serum and selenium concentrations on GPX activities (nmol 
NADPH oxidized/min/mg protein) in 4-day differentiated L8 myotubes cultured for 
various times (16, 24 or 48 hr). Culture media is basal media (without serum), basal 
media with lir M selenite,  differentiation media (basal media + 2%CS), or 
differentiation media with 10-7M selenite. 120 
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Figure 4-5C. Effects of serum and selenium concentrations on GPX activities (nmol 
NADPH oxidized/min/mg protein) in 4-day differentiated L8 myotubes cultured for 
various times (16, 24 or 48 hr). Culture media is basal media (without serum), basal 
media with  10-6 M selenite,  differentiation media (basal media + 2%CS), or 
differentiation media with 10-8M selenite. 
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Figure 4-6A.  Effects of different forms of selenium  (10-6M of selenite,  L-
selenomethionine or L-selenocystine) on selenoprotein W levels of 4-day differentiated 
L8 myotubes incubated for 16 hr). Different electrophoresis was performed for the 
various time period, thus the difference can only be compared within the same incubation 
time. 122 
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Figure 4-6B.  Effects of different  forms of selenium  (10-6M of selenite,  L-
selenomethionine or L-selenocystine) on selenoprotein W levels of 4-day differentiated 
L8 myotubes incubated for 24 hr. Different electrophoresis was performed for the various 
time period, thus the difference can only be compared within the same incubation time. 123 
2500 
C  
2000 
cti 
1500 
1000 
500 
Selenite  Se Met  SeCys 
Forms of Selenium 
Figure 4-6C.  Effects  of different forms of selenium  (10-6M of  selenite,  L-
selenomethionine or L-selenocystine) on selenoprotein W levels of 4-day differentiated 
L8 myotubes incubated for 48 hr. Different electrophoresis was performed for the various 
time period, thus the difference can only be compared within the same incubation time. 124 
differences among these 3 selenium forms at 16 and 24 hr incubation (p > .05). After 
48 hr incubation, selenite appeared to be the most available form of selenium for muscle 
cell usage (p < .05).  There were no differences  between  selenium  forms  as 
selenocystine and selenomethionine (p > .05). The availability of different selenium 
forms  for  selenoprotein W synthesis  is  sodium  selenite  >  selenocystine = 
selenomethionine (p < .05). 
Effects of different selenium concentrations and type of media on selenoprotein 
W level at various times are shown in Fig. 4-7. Addition of selenium in incubation media 
caused an increase (p < .05) in selenoprotein W level (Fig. 4-7), but there was no 
difference among myotubes incubated with various selenium concentration at 16 hr (Fig. 
4-7A). Selenium concentration as 10' M caused the highest selenoprotein W level (p < 
.05) at 24 hr incubation (Fig. 4-7B) whereas selenium concentration of 10' M and 10' 
M gave similar results (p > .05) at 48 hr incubation (Fig. 4-7C). 
Table 4-4 shows the effects of selenium concentration at 10' M and serum on 
selenoprotein W levels at 48 hr of incubation. Selenoprotein W level in myotubes 
incubated with basal media plus selenium was significantly higher than other incubation 
media (p < .05). There were no significant differences among myotubes incubated in 
other media (p > .05). Similar to GPX activity, the selenoprotein W levels between 
myotubes incubated in basal media with selenium and differentiation media with selenium 
did not differ significantly (p > .05). 125 
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Figure 4-7A. Effects of different selenium concentrations (10-8 M, 10' M or 10' M Se 
as selenite) on selenoprotein W levels of 4-day differentiated L8 myotubes incubated for 
16 hr. Bar 1: differentiation media (basal media + 2%CS), Bar 2: differentiation media 
+ 10' M Se, Bar 3: differentiation media + 10' M Se, Bar 4: differentiation media + 
M Se. Different electrophoresis was performed for the various time period, thus the 
difference can only be compared within the same incubation time. 126 
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Figure 4-7B. Effects of different selenium concentrations (10-8 M, 10' M or 10" M Se 
as selenite) on selenoprotein W levels of 4-day differentiated L8 myotubes incubated for 
24 hr. Bar 1: differentiation media (basal media + 2%CS), Bar 2: differentiation media 
+ 10-8 M Se, Bar 3: differentiation media + 10-7 M Se, Bar 4: differentiation media + 
10' M Se. Different electrophoresis was performed for the various time period, thus the 
difference can only be compared within the same incubation time. 127 
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Figure 4-7C. Effects of different selenium concentrations (10' M, 10' M or 10' M Se 
as selenite) on selenoprotein W levels of 4-day differentiated L8 myotubes incubated for 
48 hr. Bar 1: differentiation media (basal media + 2%CS), Bar 2: differentiation media 
+ 10' M Se, Bar 3: differentiation media + 10' M Se, Bar 4: differentiation media + 
M Se. Different electrophoresis was performed for the various time period, thus the 
difference can only be compared within the same incubation time. 128 
Table 4-4. Effects of serum and selenium concentrations on selenoprotein W level and 
GPX activity in 6-day differentiated L8 myotubes. 
Media  Se-W level  GPX activity 
Basal media + 10%CS  392±49a  99.2±2.4a 
Differentiation media (DM)  141±65"  83.3±7.8" 
DM + 10-8 M Selenite  442±116a  109.9±5.3a 
* Values are expressed as mean ± S.E. Different superscripts denote significant difference 
(p < .05). Selenoprotein W level is expressed as scan unit whereas GPX activity is 
expressed as nmol NADPH oxidized/min/mg protein. 
** L8 muscle cells were cultured in basal media with 10% CS to reach confluence, then 
incubated in various media to differentiate for 6 days. 
*** Differentiation media = basal media + 2% CS. 129 
Another study was conducted to establish that selenium was the major factor 
controlling selenoprotein W content rather than serum concentration. Table 4-5 showed 
the selenoprotein W level and GPX activity for myotubes in various differentiation media 
for 6 days. The selenoprotein W levels and GPX activities between myotubes incubated 
in basal media with high serum concentration (10% CS) and low serum concentration 
(2%CS) differed significantly (p < .05). However, addition of selenium to low serum 
media resulted a significant increase (p < .05) of selenoprotein W level and GPX 
activity, but these increases in selenoprotein W level and GPX activity did not differ 
significantly from those of high serum media (p > .05). These results suggested that the 
lower selenoprotein W level and GPX activity found in myotubes incubated with lower 
serum media was due to the decreased selenium concentration which was provided by 
serum in media. 
Northern blot analysis indicated that selenium influenced the mRNA level for 
selenoprotein W (Fig. 4-8).  The differences in intensity of the bands indicate that 
selenium affected the mRNA levels. 
The calculated results are shown in Table 4-6.  There is no difference in 18 S 
rRNA levels among different media (p > .05).  This was used as an internal control 
probe. The results indicated that selenoprotein W mRNA of L8 myotubes incubated in 
various selenium concentrations reached a plateau at concentration of 104 M in response 
to selenium. 130 
Table 4-5. Effect of serum and selenium concentrations on selenoprotein W levels in 4-
day differentiated L8 myotubes incubated for 48 hours. 
Media  Se-W level (scan unit) 
Basal media  359±31a 
Basal media +10-6M Se  1446±-576b 
Differentiation media  210±26' 
Differentiation media +10-6M Se  318±113' 
* Values are expressed as mean ± S.E. Different superscripts denote significant difference 
(p < .05). Selenoprotein W level is expressed as scan unit whereas GPX activity is 
expressed as nmol NADPH oxidized/min/mg protein. 
** Basal media = without serum. Differentiation media = basal media + 2 %CS. 131 
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Figure 4-8. Northern blot analysis of total RNA from rat L8 myotubes. 4-day 
differentiated myotubes were incubated in differentiation media with additions of various 
concentrations of selenium as selenite for 48 hr. A: hybridization with selenoprotein W 
cDNA probe. B: hybridization with internal control probe (16 S rRNA oligonucleotides). 
Lanes 1-3: initial control, lanes 4-6: differentiation media (basal media + 2%CS), lanes 
7-9: differentiation media + 10-6 M Se, lanes 10-12: differentiation media + 10' M Se, 
lanes 13-15: differentiation media + 10-8 M Se. 132 
Table 4-6. Effect of various selenium concentrations on selenoprotein W mRNA level in 
4-day differentiated L8 myotubes incubated for 48 hours, as shown in figure 4-8. 
Media  Se-W mRNA  18 S rRNA  Ratio 
Differentiation media (DM)  1684±121ac  3525±158  0.48±0.03a 
DM + 10-8M Se  1367±1338  1803±537  0.81±0.10" 
DM + 10-7M Se  2008±50'  2169±103  0.93±0.02" 
DM + 10-6M Se  2499±221"  3159±650  0.93±0.02" 
* Values are expressed as mean ± S.E. Different superscripts denote significant difference 
(p < .05). Selenoprotein W mRNA and 18 S rRNA are expressed as scan units. Ratio 
= Se-W mRNA/ 18 S rRNA. 133 
DISCUSSION  
In general, L8 muscle cells were cultured in basal media with 10% calf serum to 
reach confluence and then serum concentration of media was reduced to 2% to induce the 
differentiation of myotubes (Fig. 4-1; Table 4-1). The decrease in selenoprotein W level 
during muscle cell differentiation was due to the lower selenium concentration in media. 
However, selenoprotein W level did not change during muscle cell differentiation (Table 
4-2). In addition, selenoprotein W level and GPX activity in myotubes cultured in high 
serum media (10%CS) were higher than those cultured in low serum media (2 %CS), 
whereas selenoprotein W level and GPX activity were similar in myotubes cultured in low 
serum media with selenium addition (2 %CS + 10' M Se) and high serum media (Table 
4-4). These data indicated that the decrease in selenoprotein W during differentiation was 
due to the lower selenium concentration which was provided by serum in the media. 
Selenium is obviously involved in regulation of selenoprotein W in L8 muscle cells. Thus, 
L8 muscle cells can be used as a model to study the influence of selenium on 
selenoprotein W levels. 
Concentration of selenium in media regulated the level of selenoprotein W in L8 
muscle cells (Fig. 4-3; Table 4-3; Fig. 4-7). When selenium was reduced in the media, 
the selenoprotein W content decreased. When selenium was higher in the culture media, 
the levels of this protein likewise increased.  This is similar to the results obtained in 
vivo.  Supplementation of diets with selenium for rats (17) and sheep (18) result in 
increased levels of selenoprotein W in tissues. Muscle is more responsive than other 
tissues and thus the selenoprotein W level increased to a greater extent in muscle upon 134 
selenium addition. Likewise, when selenium is limited in the diet, the levels of this 
selenoprotein were low. These results indicates that selenium regulates selenoprotein W 
both in vivo and in vitro, and indicates that in vitro results mimics the in vivo results. 
In general, the pattern for GPX activity was similar to that for selenoprotein W 
levels in the present work. When this was studied in various tissues of sheep, there was 
no correlation between these two selenoproteins in various tissues examined, whereas the 
patterns for these two selenoproteins were similar in ovine muscle (18). This suggests 
differential regulations of selenoprotein W and GPX among the various tissues. However, 
the regulation of these two selenoproteins appears to be similar in muscle both in vivo and 
in vitro. 
Among the three different forms of selenium, selenite is the most available one 
for  both  selenoprotein W and GPX synthesis  in  L8 muscle  cells,  whereas 
selenomethionine is the least effective form (Fig. 4-4; Fig. 4-6). The reduced ability of 
L8 cells to utilize selenomethionine for selenoprotein W and for GPX activity is in 
agreement with prior work on GPX induction (12, 13, 26).  In the work with human 
lymphocytes, there was no correlation between uptake of selenium and induction of GPX 
activity. Selenocysteine was incorporated at three times the rate of selenite, and 
selenomethionine at 15 times the rate of selenite. Thus, the lower activity of GPX with 
addition of selenomethionine is not due to less uptake by the cells. This is likely due to 
the non-specific incorporation of selenomethionine in place of methionine during 
selenoprotein synthesis (12). However, selenite was found to be more effective than 
selenomethionine for GPX induction in lymphocytes (26). 135 
To verify the specific incorporation of selenocystine and selenomethionine, L8 
myotubes were incubated in media with addition of cysteine or methionine for 48 hr. 
However, selenoprotein W levels and GPX activities did not differ significantly (p > .05) 
between cells incubated with these amino acids (data not shown). These results indicate 
that the incorporation of selenocystine and selenomethionine into selenoproteins is 
selenium-dependent. 
It had been reported that only one-third of whole body selenium was used for GPX 
synthesis and two-third of whole body selenuim was used for synthesis of other 
selenoproteins in rat tissues (31). Our data indicated that the response of selenoprotein W 
to selenium in muscle cells was more sensitive and rapid than was GPX. Selenoprotein 
W showed responses to selenium addition as low as 10' M for 16 hr (Fig. 4-7A), 
whereas GPX activity did not show differences until additions at 10' M selenium for 48 
hr were used (Fig. 4-5B). This implies that the priority usage for selenium in media is 
for selenoprotein W synthesis, followed by GPX synthesis in L8 muscle cells. 
Among various selenium concentration,  10-7 M selenium is  the optimum 
concentration for maximum synthesis of selenoprotein W and GPX in L8 muscle cells 
(Fig. 4-4; Fig. 4-5; Fig 4-7). This is consistent with work on GPX induction. Based on 
GPX activity, the selenium requirements of four cell types was 10' M when selenite was 
used as the selenium source (13, 27).  This is also consistent with growth patterns. 
Selenium requirements appeared to be maximum for growth at 10' M for human 
fibroblast, mouse myoblast and ovine fibroblast, but the Chang liver cells grew just as 
well on a basal media, which contained 10' M selenium, as on the selenium 136 
supplemented ones. This suggests that the selenium requirements vary between different 
cell types (27). 
The results in our study indicated that selenium regulates selenoprotein W 
synthesis both in transcription and translation. Northern blot analysis showed that 
selenoprotein W mRNA increased to maximum at selenium concentration of 10-8 M in 
cultured L8 myotubes for 48 hr (Fig. 4-8; Table 4-6), whereas selenoprotein W level 
reached a plateau at selenium concentration of 10' M (Fig. 4-7). During selenoprotein 
synthesis, selenium is co-translationally inserted into selenoprotein sequence. However, 
in our study the results indicated that in addition to translational regulation, selenium also 
regulates selenoprotein W synthesis at the transcriptional level. This is consistent with the 
study in kidney cells which showed that mRNAs of GPX and 5' -DI were regulated by 
selenium concentration in cultured media (32). Whether selenium regulates gene 
expression of selenoprotein W directly or indirectly still needs to be further investigated. 
Selenoprotein W level in L8 myotubes incubated in basal media (without serum) 
with addition of selenium for 48 hr was significantly higher (p < .05) than that in 
myotubes incubated in low serum media (2% CS) with addition of selenium (Table 4-4). 
This result implies that serum may have a negative effect. To investigate the possibility 
that serum protein may bind selenium and reduce the availability of selenium for cell 
usage, differentiation media with and without serum were used. Each media were 
supplemented with 3 different concentrations (10-6M, 10-7M and 10-8M) of selenium as 
selenite, then incubated at 37°C for 48 hr. TCA were added to precipitate proteins, and 
the mixtures were centrifuged at 4°C for 10 mins.  Supernatants and precipitates were 
separated and the selenium content measured. If serum proteins do not interfer with 137 
selenium availability, the selenium content among precipitates of differentiation media 
with various selenite concentrations should remain unchanged. However, the preliminary 
result indicated that selenium content in precipitate of differentiation media increased as 
selenium concentration increased (data not shown). This implies that proteins in serum 
may be involved in binding the selenium and reduces its availability to the muscle cells. 
However, further experiments are needed to investigate the serum effect on selenium. 
Like selenoprotein P and MCS protein, the metabolic function of selenoprotein W 
is unknown. Selenium deficiency in lambs and calves results in white muscle disease, a 
disorder characterized by degeneration of both skeletal and cardiac muscles (28).  In 
humans, severe dietary selenium deprivation in discrete regions of China is associated 
with an endemic juvenile cardiomyopathy called Keshan disease (29). Muscle weakness 
in patients on long-term parenteral nutrition can be alleviated and prevented by selenium 
supplementation (30). Therefore, there is sufficient evidence to indicate that selenium is 
important for normal muscle metabolism. Selenoprotein W is present in muscle at higher 
concentration than in other tissues, and in selenium deficient animals selenoprotein W 
level decreased dramatically in muscle (18). It is unknown whether selenoprotein W has 
any significant role in muscle metabolism, but its sensitive and rapid responses to 
selenium status indicates that it may play a role in muscle metabolism. Further studies 
to identify the possible function of selenoprotein W are necessary. 138 
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ABSTRACT 
Since selenium increases the levels of other selenoproteins, the influence of this 
element on selenoprotein W content was examined. The effect of dietary selenium on 
tissue selenoprotein W was examined in wether sheep fed either a low selenium diet or 
the same diet supplemented with 3 mg selenium as selenite per kg diet.  Muscle biopsies 
were taken initially and at 3.5, 7.0 and 10.5 weeks afterwards. The sheep were killed 
after the last muscle biopsy and samples from nine tissues were taken. Selenoprotein W 
was determined in tissues by western blots hybridized with a polyclonal antibody against 
a synthetic peptide based on the protein sequence of the homologous rat selenoprotein 
W. In supplemented animals, muscle selenoprotein W significantly increased over initial 
levels (p < .05) whereas in animals consuming the low selenium diet muscle 
selenoprotein W levels declined significantly (p < .05).  This selenoprotein exists in 
various amounts among tissues examined. Highest levels were found in skeletal muscles 
and heart. Liver had the lowest level of selenoprotein W among the tissues examined. 
In supplemented sheep,  the selenoprotein W tissue levels and tissue selenium 
concentrations were significantly higher (p < .05) than those in unsupplemented sheep, 
except for brain.  The selenoprotein W levels in brains of both groups were not 
significantly different (p > .05), whereas selenium concentrations in brains of 
supplemented animals were significantly higher than those of unsupplemented animals (P 
< .05). 143 
INTRODUCTION  
Evidence for a low molecular weight selenium-containing protein in muscle, now 
called selenoprotein-W, was first reported in 1969 (Pedersen et al., 1969). The presence 
of this protein was noted in subsequent work (Black et al., 1978; Pedersen et al., 1972), 
but it was only purified recently (Vendeland et al., 1993). Interest in this protein arose 
from possible involvement in the etiology of the sheep nutritional myopathy, white muscle 
disease. Failure to incorporate selenium into this protein in selenium deficient lambs is 
associated with the myopathy (Pedersen et al., 1972). Demonstration that the selenium 
in a partially pure preparation of the protein was in the form of selenocysteine (Beilstein 
et al., 1981) provided supporting evidence that the protein was a true selenoprotein as 
opposed to selenium bound to protein sulfhydryls (Ganther and Corcoran, 1969), or 
random incorporation of selenomethionine for methionine in proteins (McConnell et al., 
1974). 
Synthesis of several other selenocysteine containing proteins is regulated by dietary 
selenium (Arthur et al., 1990; Behne et al., 1990; Burk and Hill, 1993 and Sunde, 1990). 
Previous studies of the relationship of selenoprotein W to dietary selenium in sheep (Black 
et al., 1978) and rats (Beilstein and Whanger, 1985) were based on the observation of the 
incorporation of radiolabeled 'Se into a low molecular weight fraction of muscle cytosol. 
The availability of antibodies which recognized the selenoprotein in a number of species 
(Yeh et al., 1995) made it feasible to precisely determine levels of the protein during 
dietary manipulation. 144 
In the current study selenoprotein W was measured in muscle biopsies collected 
from sheep as they were either supplemented or depleted of selenium. After 10.5 weeks 
of feeding these diets, the sheep were killed and the selenoprotein was examined in other 
tissues. 145 
MATERIALS AND METHODS  
Six wether sheep of mixed breed about six months of age were divided into two 
groups. One group was fed the basal diet of pelleted alfalfa (Verne!! Pellet Company, 
Corvallis, OR) which contained 15% protein, 1% fat, 35% fiber and 0.020 mg selenium 
per kg. The other group was fed the same pellets with selenite added at 3 mg selenium 
per kg. Feed was provided ad libitum, but there was no difference in feed consumption 
between the two groups during the study (p > .05). 
Biopsies of the biceps femoris muscle were taken from each sheep initially and at 
3.5, 7.0 and 10.5 weeks after beginning the experimental diets. Blood was taken from 
the jugular vein at the same time of biopsy.  After a sample was taken for selenium 
analysis, the blood was centrifuged to separate the plasma from erythrocytes. The plasma 
was frozen at -70° C until analysis. Selenium concentration and glutathione peroxidase 
(GPX, EC 1.11.1.9) activity were determined on the plasma samples. For surgery, sheep 
were first anaesthetized with Biotal (Boehringer Ingelheim Animal Health, Inc., St. Louis, 
MO) and maintained under anaesthesia with Halothane (Halocarbon Laboratory, River 
Edge, NJ). A lateral incision was made to access the biceps femoris.  Fascia and 
connective tissue were cleaned to remove a 1 g portion of the caudal biceps femoris. 
This muscle was then immediately frozen at -70° C until analysis. The remaining biceps 
femoris was sutured and the wound closed. Animals were sprayed with Furox topical 
antibiotic  (Solvay Animal Health,  Inc.,  Mendota Heights, MN) and injected 
intramuscularly with Liquimycin LA-200 antibiotic (Pfizer Animal Health, New York, 
NY) to prevent infection. Animals were monitored for two weeks following surgery to 146 
ensure complete recovery.  At the end of the experiment, animals were sacrified by 
exsanguination after being stunned with a stun-gun and samples of two muscles (biceps 
femoris and semitendinosus), heart, tongue, brain, lung, spleen, kidney and liver were 
quickly removed and frozen on dry ice. Tissue samples were subsequently stored at -70° 
C until analysis. 
Tissues were homogenized in 6 volumes of buffer (20 mmol/L Tris [pH 7.5], 0.25 
mol/L sucrose, 1 mmol/L EGTA, 5 mmol/L EDTA, 1 mmol/L phenylmethylsulfonyl 
fluoride, 50 mmol/L 2-mercaptoethanol and 0.025 g/L leupeptin) and the homogenates 
were centrifuged at 17,000 x g for 10 minutes at 4°C to obtain cytosolic extracts. GPX 
enzyme activity was determined in extracts by the method of Paglia and Valentine (1967) 
and protein concentrations were measured by the dye-binding assay (Bradford, 1976) 
using bovine serum albumin as standards.  After digestion with nitric and perchloric 
acids, selenium content of whole blood, tissue samples and extracts were determined by 
a semi-automated fluorometric assay (Brown and Watkinson, 1977) with an Alpchem II 
system (Alpchem Corp., Milwaukie, OR). 
Tissue extracts were electrophoresed on 7.5%  to  15 % gradient SDS-
polyacrylamide gels as described by Laemmili (1970) and proteins were transferred onto 
nitrocellulose membranes (0.2 um, BA-S83; Schleicher & Schuell, Keene, NH) according 
to the method of Towbin et al. (1979). Pure rat selenoprotein W ranged from 5 to 20 ng 
were included in each gel to use as standards. Selenoprotein W contents in tissue extracts 
were determined in Western Blot analysis as described by Yeh et al. (1995), using a 
rabbit polyclonal antibody against the peptide sequence corresponding to amino acid 
residues 13 to 31 of rat selenoprotein W. After hybridization with horseradish peroxidase-147 
conjugated goat anti-rabbit IgG (Bio-Rad, Richmond, CA), blots were incubated with 
ECL chemiluminescent reagent (Amersham Life Sciences Inc. , Arlington Heights, IL) and 
exposed to Kodak X-OMAT film (Eastman Kodak Co., Rochester NY). Developed films 
were scanned with a Personal Densitometer SI (Molecular Dynamics, Sunnyvale, CA) and 
analyzed by the ImageQuaNT program (Molecular Dynamics, Sunnyvale, CA). 
Statistical analyses were performed by the Student-Newman-Keuls t-test and 
analysis of variance (ANOVA) with Fisher's least-significant difference (LSD) method 
for comparing groups (Steel and Torrie, 1980). A significant level of 5 % was adopted 
for all comparisons. This study was approved by the animal care committee of Oregon 
State University. 148 
RESULTS  
There were no significant differences in muscle GPX activity, muscle selenium 
contents, muscle selenium selenoprotein W content, whole blood selenium concentration, 
plasma selenium concentration or plasma GPX activity between the sheep at the initiation 
of this experiment, indicating that their selenium status was similar.  The selenium 
concentration in the whole blood is shown in figure 5-1. The selenium concentration in 
the deficient sheep gradually dropped from 3.4 X 10-6 mol/L to 1.9 X 10' mole/L at the 
end of the experiment (p < .05). As expected, the selenium concentration in the whole 
blood of the supplemented sheep increased significantly (p < .05) throughout the study, 
reaching a mean level of 1.1 X 10-5 mol/L at the end of the study. 
Figure 5-2 shows the Western blot for muscle biopsy samples at various times 
from the two groups of sheep.  Based on the intensity of the bands, the levels of 
selenoprotein W increased over time in supplemented sheep whereas this decreased in 
deficient sheep. 
The selenoprotein W in the muscle (figure 5-3) followed similar patterns as the 
blood. The concentration of this selenoprotein gradually dropped from about 24 to 15 ng 
per mg protein at the end of the study (p < .05).  In contrast, there was a significant 
increase (p < .05) of this selenoprotein in the muscle of supplemented sheep. The 
selenoprotein W concentrations in muscles of supplemented sheep were significantly 
higher (p < .05) at 3.5 weeks and 7.0 weeks in comparison to the initial values and the 
10.5 weeks values were significantly higher (p < .05) as compared to the earlier ones. 
This is similar to the blood selenium patterns. 149 
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Figure 5-1. Blood selenium levels in sheep fed for various times the basal diet or those 
fed this diet plus 3 mg selenium per kg. The values are presented as means ± SEM (as 
indicated by error bars). 150 
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Figure  5-2. Western blot of muscle samples taken from sheep fed the deficient or 
supplemented diets for various times. Lanes 1-3: sheep fed Se-deficient diet for 3.5 wks. 
Lanes 4-6: sheep fed Se-supplemented diet for 3.5 wks. Lanes 7-9: sheep fed Se-deficient 
diet for 7.0 wks. Lanes 10-12: sheep fed Se-supplemented diet for 7.0 wks. Lanes 13-15: 
sheep fed Se-deficient diet for  10.5 wks. Lanes 16-18: sheep fed Se-supplemented diet 
for 10.5 wks. 151 
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Figure 5-3. Selenoprotein W content in muscle from sheep fed for various times the basal 
diet or those fed this diet with 3 mg selenium per kg. The values are presented as means 
± SEM (as indicated by the error bars). 152 
The selenium content in muscles of deficient sheep decreased gradually (p <  .05) 
whereas those in muscles of supplemented sheep increased dramatically (p <  .05) and 
reach a plateau after 3.5 weeks of supplementation (figure 5-4).  The selenium content 
in the muscle cytosols followed the same patterns as the selenoprotein W content (data 
not shown). 
The GPX activity of the muscle followed similar trends but did not duplicate the 
results with selenoprotein W (figure 5-5). As expected, GPX activity dropped (p <  .05) 
to the lower point after  3.5 weeks in the deficient sheep whereas GPX activity of 
supplemented sheep increased dramatically (p <  .05) and reached a plateau after  3.5 
weeks of supplementation. The patterns of muscle GPX activitiy and muscle selenium 
content in supplemented sheep were similar. 
The selenoprotein W content of the various tissues is shown in figure 5-6.  The 
selenoprotein W content was significantly lower (p <  0.05 to 0.01) in all tissues of the 
control, except for the brain, than the supplemented sheep. The selenoprotein W content 
was highest in muscle and heart, following by brain, tongue, spleen, kidney, lungs and 
liver in decreasing order. Since the selenoprotein W content was the same for the biceps 
femoris and semitendinosus muscles, the average values for each of these are presented 
in this figure. 
The selenium content in the whole tissues followed a different pattern than 
selenoprotein W (figure 5-7).  The selenium content was highest in the liver, followed by 
kidney, lung, spleen, heart, tongue, brain, and the muscles (combined biceps femoris and 
semitendinosus) in decreasing order. The selenium content was significantly higher 153 
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Figure 5-4. Selenium content in muscle from sheep fed for various times the basal diet 
or those fed this diet with 3 mg selenium per kg. The values are presented as mean ± 
SEM (as indicated by the error bars). 154 
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Figure 5-5. Glutathione peroxidase activity in muscle from sheep fed for various times 
the basal diet and those fed this diet with 3 mg selenium per kg. The GPX activity is 
expressed as nmol NADPH oxidized/min/mg protein. The values are presented as means 
± SEM (as indicated by the error bars). 155 
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Figure 5-6. Selenoprotein W content in different tissues from sheep fed the basal diet or 
those fed the basal diet with 3 mg selenium per kg. The values are presented as means 
± SEM (as indicated by error bars). 156 
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Figure 5- 7. Selenium content of various whole tissues from sheep fed the basal diet and 
those fed this diet plus 3 mg selenium per kg. The values are presented as means ± SEM 
(as indicated by error bars). 157 
(p < 0.05 to 0.01) in all tissues from the supplemented sheep than in those from sheep 
fed the deficient diet. The selenium in the cytosols from these tissues followed the same 
patterns (data not shown). 
The GPX activity in the various sheep tissues did not follow the pattern of either 
the selenium content or the selenoprotein W levels (figure 5-8). This activity was lower 
in all tissues, except brain, from the deficient sheep than those from the supplemented 
ones (p < .05 to 0.01). GPX activity was highest in the spleen, followed by lung, heart, 
tongue, kidney, brain, muscles (combined biceps and semitendinosus) and liver in 
decreasing order. Thus, it is evident that the distribution of selenium, selenoprotein W 
and GPX between tissues do not follow similar patterns. There are no correlations among 
the relative tissue distributions of selenium, selenoprotein W content and GPX activity. 158 
500 
a) 
0 
400 
a> 
E  300 
*E 
D 
> 
Zi 
as 
X 
0-
200 
100 
0 
Muscle  Heart Tongue  Brain  Lung 
Tissues 
Spleen Kidney  Liver 
Figure 5-8. Glutathione peroxidase activity in different tissues from sheep fed the basal 
diet or those fed the diet with 3 mg selenium per kg. The GPX activity is expressed as 
nmol NADPH oxidized/min/mg protein. The values are presented as means ± SEM (as 
indicated by error bars). 159 
DISCUSSION  
The cDNA for selenoprotein W from sheep muscle has now been sequenced, and 
this selenoprotein was found to be conserved between the rat and sheep (Gu et al., 1996). 
The antibody raised against the peptide sequence of rat selenoprotein W was shown to 
cross-react  with ovine tissues (Yeh et al., 1995). Thus, this antibody was used in 
Western blot analysis in the present study. 
These results indicate that there are no correlations among the relative tissue 
distribution of selenium, GPX and selenoprotein W. Selenoprotein W was highest in 
muscle and heart (figure 5-6), selenium was highest in liver (figure 5-7), whereas GPX 
was highest in the spleen (figure 5-8) for selenium-supplemented sheep. There was a 
significant correlation of muscle selenoprotein W content with the selenium levels (P < 
0.002), with muscle cytosolic selenium (P < 0.005), and with muscle GPX activity (P 
< 0.003). As expected, when all tissues were considered there was no correlation of 
tissue selenoprotein W content with tissue selenium, tissue cystosol selenium or with 
tissue GPX activity.  White muscle disease is a selenium deficient myopathy where 
lesions occur in the muscle and heart (Schubert et al., 1961). Because selenoprotein W 
is highest in these organs in sheep given selenium, it is tempting to speculate its 
involvement in the prevention of this disorder in these organs. 
Deficient and 3 mg selenium per kg diet were compared to determine whether 
there was a difference in selenoprotein W levels between extremely wide selenium status. 
Now that it has been established that selenoprotein W levels increase with supernutritional 
levels, nutritional levels will now be tested.  However, it should be noted that in rats 160 
selenoprotein W levels in muscle reaches a plateau only after 1 mg selenium per kg diet 
is fed (Yeh et al., unpublished data).  It will be of interest to determine whether similar 
patterns are obtained with sheep. 
There were no difference (p > .05) in the selenoprotein W content in the brain 
between the sheep fed the deficient diet and those given selenium (figure 5-6), but there 
was a 53% difference in the total selenium content (figure 5-7). The GPX activity was 
higher (p < .05) in this organ of the deficient sheep than that of supplemented sheep 
(figure 5-8). However, the regulations of selenium and selenoprotein synthesis in brain 
appear to be different from those in other tissues. Davidson and Kennedy (1993) indicated 
that there is greater synthesis of the selenoproteins in deficient sheep. Brain may regulate 
its selenoprotein levels to balance the selenium content during selenium deficiency or 
selenium toxicity. In our study, it shows that selenoprotein W content in brain did not 
change due to selenium deficiency or supplementation. However, GPX activity was higher 
and the selenium content was 53% lower in brain of deficient sheep. Therefore, the 
regulations of these two selenoproteins are different in brain. Further studies are needed 
to investigate the significance of these observations. 
Neither the tissue distribution or its characteristics offer any clues on the metabolic 
functions of selenoprotein W. It contains one gram atom of selenium per mole protein 
(Vendeland et al, 1993) and reduced glutathione is bound to one species of this protein 
(Beilstein et al, 1995). Since all the selenoenzymes which have been identified thus far 
are involved in redox reactions (Burk and Hill,  1993; Sunde, 1990),  it appears 
advantageous to postulate a role for selenoprotein W as an antioxidant, especially since 
glutathione is one of its binding moieties. 161 
Selenoprotein W is one of three mammalian selenoproteins which have been well 
characterized without identified functions. Of these, selenoprotein P has been studied to 
the greatest extent. The majority of the selenium in plasma of rats (Read et al, 1990) and 
humans (Deagen et al, 1993) has been shown to be associated with this protein. It is the 
highest selenium containing protein known, with ten selenocysteine residues per mole 
protein (Hill et al, 1991). Similar to selenoprotein Win tissues, the level of selenoprotein 
P in plasma is affected by the selenium status of the animal (Yang et al, 1969). The only 
other selenoprotein known to possess more than one selenocysteine residues per subunit 
is mitochondria) capsule selenoprotein (MCS) from mouse sperm, which interestingly 
contains all three selenocysteines in the first 35 amino acids of a total of 197 residues 
(Karimpour et al, 1992). The cDNA for selenoprotein W has been recently cloned and 
it is similar to MCS in that the selenocysteine residue is in the early part (number 13) of 
the molecule (Vendeland et al, 1995). This is in contrast to selenoprotein P where most 
of the selenocysteine residues are in the last part of the protein (Hill et al, 1991). 
A family of GPXs and type 1 iodothyronine 5 '-deiodinase are the only mammalian 
selenoenzymes presently known. The cellular GPX was recognized about 20 years ago 
(Rotruck et al, 1973) and represented the only biochemical function of selenium for many 
years. A plasma GPX was shown to be immunochemically distinct from the cellular 
enzyme (Takahashi et al, 1987), and is clearly a separate gene product from the cellular 
one (Takahashi et al, 1990). A third GPX was identified which reduces fatty acid 
hydroperoxides esterified to phospholipids (PHGPX), and assumed to play a significant 
role in reducing peroxides in membranes (Schuckelt et al, 1991). A fourth GPX has been 
found predominantly in the gastrointestinal mucosa (Chu et al, 1993).  Except for 162 
PHGPX, which is a monomer, all GPXs are tetramers and have one selenocysteine 
residue per subunit. The deiodinase contains one selenocysteine per mole protein (Behne 
et al, 1990; Berry et al, 1991) and converts thyroxine to triiodothyronine, providing a 
metabolic link between selenium and iodine. The relationship of selenoprotein W to these 
selenoenzymes is not known, but the present results indicate a different tissue distribution 
from them. 
Up to 13 selenium containing proteins have been reported in rat tissues (Behne et 
al, 1988) and up to 9 have been reported in ovine tissues (Davidson and Kennedy, 1993). 
Three to four selenium containing proteins were found in ovine heart and muscle. Thus 
far only GPX and selenoprotein W have been identified in these tissues, which suggests 
that there are at least two more to be identified in these tissues. More selenium containing 
proteins were present in other tissues such as the liver and pituitary, providing sufficient 
reasons to believe that the identification of more selenoproteins is forthcoming. 163 
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CHAPTER 6  
CONCLUSION 
Although evidence for selenoprotein W was obtained over 20 years ago, it was 
only recently purified and characterized. This selenoprotein was identified in the present 
study by Western blots.  It was not feasible to purify enough of this protein to raise 
antibodies against the native protein. Thus, an alternate procedure was used. Antibodies 
were raised against a peptide of amino acids 13 to 31. The antibody to this peptide was 
used in the Western blots to detect the presence of this selenoprotein and to obtain 
quantitative estimates of its concentration. However, a more desirable method needs to 
be developed to quantitate this selenoprotein.  As discussed in the appendix, attempts 
were made to develop such a method by an ELISA procedure.  Efforts were not 
successful in development of a method sensitive enough for this purpose and this should 
be one of the primary goals for future work. 
The antibody raised against the peptide appears to be sufficient for detecting 
selenoprotein W in tissues of rats, mice, sheep, cattle and guinea pigs. However, it may 
not be sufficient for human and higher primate tissues.  This antibody reacted with a 
protein about three times the molecular weight of selenoprotein W in primate tissues, but 
no reaction occurred at the molecular weight of selenoprotein W in the Western blots. 
The deduced amino acid sequence has now been determined from the nucleotide sequence 
of the cDNA. Since there are three major differences in the amino acid composition of 
this peptide region between rats and primates, this may account for these results. 168 
Antibodies have now been raised against the peptide from primates and these gave bands 
at the place were selenoprotein W should be in Western blots. Therefore, the antibody 
situation needs to be investigated more thoroughly. One approach would be to have E. 
coli synthesize a mutant protein and use this as the antigen to raise antibodies.  This 
would appear to be a worthy goal to pursue in the future. 
There are four species of selenoprotein W. One of these does not have any 
adducts bound to it. The second one has reduced glutathione as the adduct. The third 
species has a 45 dalton moiety bound to it and very recent evidence suggest that it is 
calcium. The fourth species has both adducts bound to it.  It is not known how calcium, 
reduced glutathione, selenium or other factors affect the relative amounts of this 
selenoprotein. A convenient method needs to be developed to quantitate these different 
species so the effects of nutritional factors on their relative concentrations can be 
assessed. 
The present work indicates that selenoprotein W is present in muscle, brain, testis 
and spleen of rats as determined by Western blot analysis. In contrast, its level is highest 
in muscle and heart of selenium-supplemented sheep. Selenium deficiency results in White 
Muscle Disease (WMD) which is a degenerative process predominatly in heart and 
skeletal muscle of lambs and calves. However, selenium deficiency does not cause the 
degeneration in heart of rats, but causes cardiac and skeletal muscle degeneration in 
lambs. The different tissue distribution of selenoprotein W in rats and sheep may 
account for this difference in affected tissues between these animals. 
The results reported in chapter 3 indicate that selenoprotein W and cGPX are 
regulated differently by selenium. Although cGPX activity in tissues reached a plateau 169 
with 0.1 mg selenium per kg diet or less, higher levels of selenium were required for 
selenoprotein W to reach a plateau. There may be some differences in the regulation of 
this selenoprotein between tissues because 1.0 mg selenium per kg was required for this 
plateau to be reached in the muscle whereas this plateau was reached with lower levels 
in other tissues. Therefore, studies on the regulation of selenoprotein W by selenium 
would appear to be a fruitful area to pursue. 
The function of this selenoprotein is still unknown. Selenoprotein W is absent in 
muscle and heart of the WMD lambs, whereas it is present in muscle and heart of normal 
animal. This may imply that selenoprotein W is involved in the prevention of WMD. 
Contractions in cardiac and skeletal muscles are controlled by the calcium transport 
system of sarcoplasmic reticulum. Calcium metabolism is altered in WMD lambs due to 
the markedly decrease in calcium transport by sarcoplasmic reticulum. Injection of 
selenium into WMD lambs results in the rapid recovery of this disease and the greater 
increase of calcium uptake by sarcoplasmic reticulum. 
The present work indicate that the response of selenoprotein W to selenium status 
was rapid and selenium-dependent both in animals and in cell culture. In rat studies, 
selenoprotein W mRNA increased significantly in muscle from those fed a diet with 0.1 
ppm selenium, and this selenoprotein level in muscle increased dramatically and reached 
a plateau with supplementation of 1 ppm selenium. In L8 muscle cells, selenoprotein W 
mRNA increased markedly and reached a plateau with addition of 10' M selenium in 
media, whereas the selenoprotein W level reached a plateau with addition of 10' M 
selenium in media. The relationship of mRNA content to the protein levels needs to be 
investigated in more detail.  Experiments need to be conducted to determine whether 170 
selenium affects transcription or mRNA stability. The available data, however, indicate 
that selenium can regulate selenoprotein W synthesis at both transcriptional and 
translational levels, but this needs to be confirmed. 
Because of its  small molecular weight and low concentration in  tissues, 
selenoprotein W probably acts as a regulatory protein. Recently, a part of selenoprotein 
W sequence (amino acids 60-71) was discovered to be highly homologous to the sequence 
of calcium-binding domains in several calcium binding proteins. Therefore, the gene for 
selenoprotein W may also be regulated by calcium binding to the calcium-binding domain. 
The increase of calcium uptake in sarcoplasmic reticulum by selenium supplementation 
to WMD animals may in turn increase selenoprotein W gene expression in muscle and 
heart of selenium-deficient animals.  It would therefore be prudent to consider calcium 
in addition to selenium in the regulation of selenoprotein W. The response of 
selenoprotein W to selenium status in L8 muscle cells mimics the patterns found in 
animals. Thus, L8 muscle cells can be used as a model to investigate the possible role of 
selenoprotein W in muscular degeneration. 171 
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APPENDIX 1. 
GENERATION AND PURIFICATION OF MONOCLONAL AND  
POLYCLONAL ANTIBODIES AGAINST RAT SELENOPROTEIN W  
The hydrophilicity was calculated from the amino acid sequence of selenoprotein 
W and two peptides were synthesized corresponding to the first two hydrophilic regions 
(amino acid residues 13-31 for peptide 1 and amino acid residues 51-69 for peptide 2) by 
Central Service Laboratory of Center for Gene Research and Biotechnologyatn Oregon 
State University. These peptides were synthesized with cysteine added to the amino-
terminal ends for conjugation to keyhole limpet hemocyanin (KLH). These KLH-
conjugated synthetic peptides were used for immunization of mice and rabbits respectively 
to generate monoclonal and polyclonal antibodies. The monoclonal antibodies were 
purified by protein A columns and polyclonal antibodies by peptide-coupled Sulfolink 
affinity  columns.  After  purification,  antibody  solutions  were concentrated by 
centrifugation with centrifuge tubes and 50% glycerol was subsequently added to the 
concentrated antibody solution. These antibody solutions were divided into aliquots and 
frozen at -20°C for later analysis. 
Generation and purification of monoclonal antibody 
Mice were immunized at 3-week intervals with KLH-conjugated peptides and bled 
7-10 days following each injection. The antisera were titered against the peptides in a 
particle  concentration  fluorescence immunoassay (PCFIA).  After 4 rounds of 183 
immunizations, the mice were given a final injection of the antigen and the apleens were 
removed 3 days later for fusions with myeloma cells. Hybridoma were selected by 
cultuing in HAT media and then cultured in RPMI media. The supernatants from single 
clonal hybridoma were assayed after 10 days growth for reactivities in the PCFIA. These 
procedures were repeated until positive clones were found. To produce ascites fluid, nude 
mice were inoculated intraperitoneally each with 2 ml of monoclonal antibody-producing 
hybridoma cells (2.5 X 106 cells/ml in Phosphate Buffered Saline [PBS]) and the ascites 
formed 1-2 weeks after injection of the hybridoma cells. The ascites were harvested by 
inserting a needle into the abdominal cavity and then centrifuged at 1500 xg for 10 min 
at room temperature. The supernatants were harvested and stored at 4°C until all 
collection was completed within one week. The ascites fluid were pooled and heat-
inactivated in a water bath at 56°C for 45 min, and the titer was determined. 
The ascites were first determined by the subclass kit (Pierce, Rockford, IL). The 
subclass of the monoclonal antibody appeared to be Ig G1 . The ascites were subsequently 
purified by using high salt conditions on protein A columns. The NaCl concentration of 
the ascites were adjusted to 3.3 M and 1/10 volume of 1.0 M sodium borate (pH 8.9) 
added to the ascites solution. This antibody solution was passed through a protein A bead 
column (Pierce, Rockford, IL). The protein A column was washed with 10 column 
volumes of buffer A (3.0 M NaC1, 50 mM sodium borate [pH 8.9]) following by 10 
column volumes of buffer B (3.0 M NaC1, 10 mM sodium borate [pH 8.9]). 0.1 M 
glycine (pH 3.0) was added stepwise to elute the antibodies which were collected in tubes 
containing 1/10 volume of 1.0 M Tris (pH 7.5). This resulted in a neutral pH. The 
fractions containing antibody were identified by absorbance at 280 nm (1 OD = 0.8 184 
mg/ml). The excellulose desalting columns were used to desalt the antibody fractions and 
exchange its buffer to PBS. 
Generation and purification of polyclonal antibody 
Rabbits were immunized at 3-week intervals with KLH-conjugated synthetic 
peptides in Freund's adjuvant for 9 weeks. Blood was taken one week after the last 
injection and the serum was collected. The polyclonal antibodies were purified from 
rabbit sera by Sulfolink affinity columns (Pierce, Rockford, IL) coupled with synthetic 
peptides. 
The synthetic peptides were dissolved in buffer A (50 mM Tris, 5 mM EDTA, 
pH 8.5). These peptide solutions were mixed with Sulfolink coupling gels for 15 min at 
room temperature and incubated for 30 min without further mixing. The Sulfolink affinity 
columns were washed with 3 column volumes of buffer A. After applying one column 
volume of freshly prepared 50 mM cysteine solution in buffer A to the column, the 
peptide-coupled gels were mixed for 15 min at room temperature and incubated for 30 
min without mixing at room temperature in order to block non-specific binding sites on 
the gels. These peptide-coupled columns were washed with 16 column volumes of 1 M 
NaCl and equilibrated with 3 column volumes of PBS. Rabbit sera were diluted with 2 
volumes of PBS and applied to the peptide-coupled columns. The columns were washed 
with 6 column volumes of PBS and the antibodies eluted with 4 column volumes of 0.1 
M glycine (pH 2.8). Forty 1-ml fractions were collected and neutralized by adding 1/20 
volume of 1 M Tris (pH 9.5). The antibody-containing fractions were identified by 185 
absorbance at 280 nm (1 OD = 0.8 mg/m1). The excellulose desalting columns were used 
to desalt and exchange buffer of antibody fractions to PBS. 
Assays of monoclonal and polyclonal antibodies 
The antibody solutions were assayed by Western blotting technique using purified 
selenoprotein W and tissue cytosols as antigens. The results from Western blot analysis 
indicated that the monoclonal antibodies recognized purified selenoprotein W but with 
very low affinity. Because of this low affinity, these monoclonal antibodies  failed to 
recognize selenoprotein W in tissue supernatants. The polyclonal antibodies against both 
synthetic peptides recognized selenoprotein W either as pure selenoprotein W or in tissue 
supernatants. However, polyclonal antibody against peptide 1 produced less non-specific 
background than polyclonal antibody against peptide 2 in the Western blot assay. 186 
APPENDIX 2.  
DEVELOPMENT OF SANDWICH ELISA ASSAY USING MONOCLONAL  
AND POLYCLONAL ANTIBODIES AGAINST SELENOPROTEIN W  
To develop a quick method for quantitating amount of selenoprotein W in animal 
tissues, two-antibodies sandwich ELISA assay was tested. Monoclonal and polyclonal 
antibodies were generated against both peptide 1 and peptide 2 of selenoprotein W and 
each of them used in the sandwich ELISA assay. 
ELISA plates were coated with purified monoclonal antibody in PBS (20 mM 
sodium phosphate, 100 mM NaC1, pH 7.4) and kept at 4°C overnight. These plates were 
blocked with Supper Block solution (Pierce, Rockford, IL) at RT for 1 hr. Either synthetic 
peptides, pure selenoprotein W or different tissue supernatants were added to the plates 
and incubated at 37°C for 1 hr. A polyclonal antibody was added to the plates and 
incubated at 37°C for an additional 1 hr. Then goat-anti rabbit IgG-HRP (Bio-Rad, 
Richmond, CA) was added to the plates and these plates were incubated at 37°C for 
another 1 hr. After adding the ABTS substrate, the plates were incubated at RT for 10 
min. Absorbance was measured by an ELISA plate reader at 405 nm. The concentration 
of selenoprotein W in tissue supernatants could be calculated from the standard curve of 
pure selenoprotein W. 
Different combinations of monoclonal and polyclonal antibodies (monoclonal and 
polyclonal antibodies against peptide 1, monoclonal antibody against peptide 2 and 
polyclonal antibody against peptide 1, monoclonal antibody against peptide 1 and 
polyclonal antibody against peptide 2, monoclonal and polyclonal antibodies against 187 
peptide 2) were used to develop the sandwich ELISA assay. The sandwich ELISA assay 
worked using synthetic peptides as antigens, but did not work  using either pure 
selenoprotein W or tissue supernatants as antigens. 
Both polyclonal  antibodies  functioned  in Western blot  assay with pure 
selenoprotein W and tissue supernatants, but monoclonal antibodies did not give bands in 
Western blot assay with tissue supernatants. Therefore,  it is not certain whether the 
monoclonal antibodies can or can not work in the sandwich ELISA assay. Due to the 
different states of proteins in the two assays (native state for ELISA assay and denatured 
state for Western blot analysis), monoclonal and polyclonal antibodies may only recognize 
the denatured state of selenoprotein W. Thus, the denatured selenoprotein W and tissue 
supernatants were also used in the sandwich ELISA assay.  Unfortunately, this approach 
was still unsuccessful. Presumably  this is due to the low affinity of monoclonal 
antibodies. To develop the sandwich ELISA assay successfully,  regeneration of 
monoclonal antibody with greater affinity will be necessary. 